TREA

SUBSTITUTED 1,4-DITHIINE DERIVATIVES AND THEIR USE AS FUNGICIDES

Follow

Information

  • Patent Application
  • 20150315212
  • Publication Number
    20150315212
  • Date Filed
    November 25, 2013
    10 years ago
  • Date Published
    November 05, 2015
    8 years ago
Information
Abstract
The present invention relates to substituted 1,4-dithiine derivatives of formula I as defined in the description, and the N-oxides, and salts thereof, their preparation and intermediates for preparing them. The invention also relates to the use of these compounds for combating harmful fungi and seed coated with at least one such compound and also to compositions comprising at least one such compound.
Description

The present invention relates to compounds of the formula I




embedded image


and the N-oxides and the agriculturally acceptable salts thereof.


Furthermore the present invention relates to a process for preparing compounds of the formula I.


Furthermore the present invention relates to agrochemical compositions, comprising an auxiliary and at least one compound of formula I an N-oxide or an agriculturally acceptable salt thereof.


Furthermore the present invention relates to the use of a compound of the formula I and/or of an agriculturally acceptable salt thereof or of the compositions for combating phytopathogenic fungi.


Furthermore the present invention relates to a method for combating harmful fungi, comprising treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of at least one compound of formula I or with a composition.


Furthermore the present invention relates to seed, coated with at least one compound of the formula I and/or an agriculturally acceptable salt thereof or with a composition in an amount of from 0.1 to 10 kg per 100 kg of seed.


Compounds of the following formula




embedded image


process for their preparation and their application in crop protection are known and described e.g. in WO 2010/043319.


WO 2011/029551 relates to the mixtures of the formula (I)




embedded image


The compounds according to the present invention differ from those described in the abovementioned publications inter alia by the substitution of the 1,4-dithiine ring by the isothiazol ring. In many cases, in particular at low application rates, the fungicidal activity of the known fungicidal compounds is unsatisfactory. Based on this, it was an object of the present invention to provide compounds having improved activity and/or a broader activity spectrum against phytopathogenic harmful fungi.


Accordingly, it is an object of the present invention to provide compounds having better fungicidal activity and/or better crop plant compatibility.


Surprisingly, these objects are achieved by compounds of the general formula I, as defined below, and by the agriculturally acceptable salts of the compounds of the general formula I.


Accordingly, the present invention relates to compounds of formula I




embedded image


in which


k is 0, 1 or 2; or


l is 0, 1 or 2; or


R1 is H, OH, halogen, CN, NO2; or

    • C1-C10-alkyl, C1-C10-alkoxy, C1-C10-haloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C3-C10-cycloalkenyl; or
    • phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein
      • the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C10-alkoxy, C1-C10-haloalkoxy; or
    • NA1A2 where
      • A1 and A2 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C1-C10-alkoxy-C1-C10-alkyl, amino-C1-C10-alkyl, or
        • independently of one another are phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein
          • the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy; or
    • OA3 where
      • A3 is C1-C10-alkyl, C1-C4-alkylcarbonyl, C1-C10-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C3-C6-cycloalkenyl, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein
        • the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy;


R2 is halogen, CN, NO2; or

    • NA1A2
    • where
    • A1 and A2 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C1-C10-alkoxy-C1-C10-alkyl, amino-C1-C10-alkyl,
      • wherein
      • the amino group is substituted by B1 and B2 which are independently of one another hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl or B1 and B2 together with the N atom to which these radicals are attached may also form a five-, six-, seven-, eight-, nine- or ten-membered saturated or partially unsaturated ring which, in addition to carbon atoms, may contain one, two or three heteroatoms from the group consisting of O, N and S as ring members;
      • or
      • independently of one another are phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO groups as ring members,
      • wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy; or
    • a radical of the formula
    • —C(═O)A4, —OC(═O)A4, —C(═O)OA4, —NA4C(═O)A4, —N═OA4,
    • where
    • A4 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO groups as ring members,
      • wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy; or
    • —S(O)nA5, —OS(O)nA5, —NA5S(O)nA5
    • where
    • n=0, 1, 2
    • A5 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO groups as ring members,
      • wherein the above mentioned groups may carry one, two, three or four halogen, hydroxyl, cyano, nitro, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy;


        and the N-oxides and the agriculturally acceptable salts thereof.


Furthermore the present invention provides a process for preparing compounds of the formula I.


Furthermore the present invention provides an agrochemical composition, comprising an auxiliary and at least one compound of formula I an N-oxide or an agriculturally acceptable salt thereof.


Furthermore compounds of the formula I and/or of an agriculturally acceptable salt thereof or of the compositions can be used for combating phytopathogenic fungi.


Furthermore the present invention provides a method for combating harmful fungi, comprising treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of at least one compound of formula I or with a composition.


Furthermore the present invention provides seed, coated with at least one compound of the formula I and/or an agriculturally acceptable salt thereof or with a composition in an amount of from 0.1 to 10 kg per 100 kg of seed.


The terms used for organic groups in the definition of the variables are, for example the expression “halogen”, collective terms which represent the individual members of these groups of organic units.


The prefix Cx-Cy denotes the number of possible carbon atoms in the particular case.


halogen: fluorine, bromine, chlorine or iodine, especially fluorine, chlorine or bromine;


alkyl and the alkyl moieties of composite groups such as, for example, alkoxy, alkylamino, alkoxycarbonyl: saturated straight-chain or branched hydrocarbon radicals having 1 to 10 carbon atoms, for example C1-C10-akyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl; heptyl, octyl, 2-ethylhexyl and positional isomers thereof; nonyl, decyl and positional isomers thereof;


haloalkyl: straight-chain or branched alkyl groups having 1 to 10 carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above. In one embodiment, the alkyl groups are substituted at least once or completely by a particular halogen atom, preferably fluorine, chlorine or bromine. In a further embodiment, the alkyl groups are partially or fully halogenated by different halogen atoms; in the case of mixed halogen substitutions, the combination of chlorine and fluorine is preferred. Particular preference is given to (C1-C3)-haloalkyl, more preferably (C1-C2)-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1,1,1-trifluoroprop-2-yl;


alkenyl and also the alkenyl moieties in composite groups, such as alkenyloxy: unsaturated straight-chain or branched hydrocarbon radicals having 2 to 10 carbon atoms and one double bond in any position. According to the invention, it may be preferred to use small alkenyl groups, such as (C2-C4)-alkenyl; on the other hand, it may also be preferred to employ larger alkenyl groups, such as (C5-C8)-alkenyl. Examples of alkenyl groups are, for example, C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl;


alkynyl and the alkynyl moieties in composite groups: straight-chain or branched hydrocarbon groups having 2 to 10 carbon atoms and one or two triple bonds in any position, for example C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl;


cycloalkyl and also the cycloalkyl moieties in composite groups: mono- or bicyclic saturated hydrocarbon groups having 3 to 10, in particular 3 to 6, carbon ring members, for example C3-C6-cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl. Examples of bicyclic radicals comprise bicyclo[2.2.1]heptyl, bicyclo[3.1.1]heptyl, bicyclo[2.2.2]octyl and bicyclo[3.2.1]octyl. In this connection, optionally substituted C3-C8-cycloalkyl means a cycloalkyl radical having from 3 to 8 carbon atoms, in which at least one hydrogen atom, for example 1, 2, 3, 4 or 5 hydrogen atoms, is/are replaced by substituents which are inert under the conditions of the reaction. Examples of inert substituents are CN, C1-C6-alkyl, C1-C4-haloalkyl, C1-C6-alkoxy, C3-C6-cycloalkyl, and C1-C4-alkoxy-C1-C6-alkyl;


halocycloalkyl and the halocycloalkyl moieties in halocycloalkoxy, halocycloalkylcarbonyl and the like: monocyclic saturated hydrocarbon groups having 3 to 10 carbon ring members (as mentioned above) in which some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine;


cycloalkenyl: monocyclic monounsaturated hydrocarbon groups having 3 to 10, 3 to 8, 3 to 6, preferably 5 to 6, carbon ring members, such as cyclopenten-1-yl, cyclopenten-3-yl, cyclohexen-1-yl, cyclohexen-3-yl, cyclohexen-4-yl and the like;


alkoxy: an alkyl group as defined above which is attached via an oxygen, preferably having 1 to 10, more preferably 2 to 6, carbon atoms. Examples are: methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy, and also for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy;


haloalkoxy: alkoxy as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine. Examples are OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2—C2F5, OCF2—C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy, 1-(CH2Br)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy; and also 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy;


6- to 10-membered aryl: aromatic cyclus with 6, 7, 8, 9 oder 10 C atoms. Examples of preferred aryl are phenyl or naphthyl;


5-, 6-, 7-, 8-, 9- or 10-membered saturated, partially unsaturated or aromatic heterocycle which contains 1, 2, 3 or 4 heteroatoms from the group consisting of O, N and S as ring members, and may furthermore contain one or two CO, SO, SO2 groups as ring members, where the heterocycle in question may be attached via a carbon atom or, if present, via a nitrogen atom. In particular:

    • a five- or six-membered saturated or partially unsaturated heterocycle which comprises one, two, three or four heteroatoms from the group consisting of O, N and S as ring members: for example monocyclic saturated or partially unsaturated heterocycles which, in addition to carbon ring members, comprise one, two or three nitrogen atoms and/or one oxygen or sulfur atom or one or two oxygen and/or sulfur atoms, for example 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4-triazolidin-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 1,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazin-2-yl and 1,2,4-hexahydrotriazin-3-yl and also the corresponding -ylidene radicals;
    • a seven-membered saturated or partially unsaturated heterocycle which comprises one, two, three or four heteroatoms from the group consisting of O, N and S as ring members: for example mono- and bicyclic heterocycles having 7 ring members which, in addition to carbon ring members, comprise one, two or three nitrogen atoms and/or one oxygen or sulfur atom or one or two oxygen and/or sulfur atoms, for example tetra- and hexahydroazepinyl, such as 2,3,4,5-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepin-1-, -2-, -3- or -4-yl, tetra- and hexahydrooxepinyl such as 2,3,4,5-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]oxepin-2-,
    • -3-, -4-, -5-, -6- or -7-yl, hexahydroazepin-1-, -2-, -3- or -4-yl, tetra- and hexahydro-1,3-diazepinyl, tetra- and hexahydro-1,4-diazepinyl, tetra- and hexahydro-1,3-oxazepinyl, tetra- and hexahydro-1,4-oxazepinyl, tetra- and hexahydro-1,3-dioxepinyl, tetra- and hexahydro-1,4-dioxepinyl and the corresponding ylidene radicals;
    • a five- or six-membered aromatic heterocycle (=heteroaromatic radical) which contains one, two, three or four heteroatoms from the group consisting of oxygen, nitrogen and sulfur, for example 5-membered heteroaryl which is attached via carbon and contains one to three nitrogen atoms or one or two nitrogen atoms and one sulfur or oxygen atom as ring members, such as 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,2,4-triazol-3-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl and 1,3,4-triazol-2-yl; 5-membered heteroaryl which is attached via nitrogen and contains one to three nitrogen atoms as ring members, such as pyrrol-1-yl, pyrazol-1-yl, imidazol-1-yl, 1,2,3-triazol-1-yl and 1,2,4-triazol-1-yl; 6-membered heteroaryl, which contains one, two or three nitrogen atoms as ring members, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl;


      C1-C10-alkoxy-C1-C10-alkyl: C1-C10-alkyl (as defined above) where one hydrogen atom is replaced by a C1-C10-alkoxy group as defined above;


      amino-C1-C10-alkyl: C1-C10-alkyl (as defined above) where one hydrogen atom is replaced by a NA1A2 group as defined above;


      mono-(C1-C10-alkyl)amino: group of the formula NA1A2 group in which A1 or A2 is an C1-C10-alkyl group as defined above.


      di-(C1-C10-alkyl)amino: group of the formula NA1A2 group in which each A1 and A2 are an C1-C10-alkyl group as defined above.


      hydroxyl: OH group which is attached via an O atom;


      cyano: CN group which is attached via an C atom;


      nitro: NO2 group which is attached via an N atom.


Depending on the substitution pattern, the compounds of the formula I according to the invention may have one or more centers of chirality, and are generally obtained in the form of racemates or as diastereomer mixtures of erythro and threo forms. The erythro and threo diastereomers of the compounds according to the invention can be separated and isolated in pure form, for example, on the basis of their different solubilities or by column chromatography. Using known methods, such uniform pairs of diastereomers can be used to obtain uniform enantiomers. Suitable for use as antimicrobial agents are both the uniform diastereomers or enantiomers and mixtures thereof obtained in the synthesis. This applies correspondingly to the fungicidal compositions.


Accordingly, the invention provides both the pure enantiomers or diastereomers and mixtures thereof. This applies to the compounds of the formula I according to the invention and, if appropriate, correspondingly to their precursors. The scope of the present invention includes in particular the (R) and (S) isomers and the racemates of the compounds according to the invention, in particular of the formula I, which have centers of chirality. Suitable compounds of the formula I according to the invention also comprise all possible stereoisomers (cis/trans isomers) and mixtures thereof.


The compounds according to the invention may be present in various crystal modifications which may differ in their biological activity. They are likewise provided by the present invention.


Owing to the basic character of their nitrogen atoms, the compounds of the formula I according to the invention are capable of forming salts or adducts with inorganic or organic acids or with metal ions.


Suitable agriculturally useful salts are especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds of the formula I. Thus, suitable cations are in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, and of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four C1-C4-alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(C1-C4-alkyl)sulfonium and sulfoxonium ions, preferably tri(C1-C4-alkyl)sulfoxonium.


Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting with an acid of the corresponding anion, preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.


The inventive compounds can be present in atropisomers arising from restricted rotation about a single bond of asymmetric groups. They also form part of the subject matter of the present invention.


Depending on the substitution pattern, the compounds of formula I and their N-oxides may have one or more centers of chirality, in which case they are present as pure enantiomers or pure diastereomers or as enantiomer or diastereomer compositions. Both, the pure enantiomers or diastereomers and their compositions are subject matter of the present invention.


The compounds of the formula I according to the invention can be prepared by different routes analogously to processes known per se of the prior art (see, for example, the prior art cited at the outset).


The compounds of the formula I according to the invention can be prepared by different routes analogously to processes known per se of the prior art as follows:


The compounds of the formula I-A according to the invention in which k=0 and l=0 can be prepared by different routes analogously to processes known per se of the prior art as follows:




embedded image


According to the above mentioned route a precursor II can be converted into the corresponding compounds of the formula (III) (for details see: Journal of Organic Chemistry, 45(25), 5122-30; 1980).


This can be coupled with the precursors (IV) providing efficient access to the corresponding compounds of the formula (I-A) (for details see: U.S. Pat. No. 5,633,219).


The compounds of the formulae I-B according to the invention in which k=1 and l=1, I-C in which k=1 and l=2, I-D in which k=2 and l=1, I-E in which k=2 and l=2 can be prepared by different routes analogously to processes known per se of the prior art as follows:




embedded image


According to the above mentioned route a precursor II can be converted into the corresponding compounds of the formula (VI) (for details see: U.S. Pat. No. 5,633,219) which can be oxided according to conventional oxidation methods, e. g. by treating compounds (VI) with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11), 1892-903, 1995) or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981) or using ammonium cerium(IV) nitrate in the presence of a catalytic amount of KBr or NaBr) (for details see: Catalysis Communications, 9(8), 1739-1744; 2008; Monatshefte fuer Chemie, 139(8), 895-899; 2008) giving the corresponding compounds of the formula (IB), (IC), (ID), (IE).


The precursor (III) may be obtained by various routes in analogy to prior art processes known from JOC, 1980, 45(25), 5122-30.


The precursor (IV) can be prepared employing a preparative procedure known from WO 2012/139987, WO 2012/40001.


If individual inventive compounds cannot be directly obtained by the routes described above, they can be prepared by derivatization of other inventive compounds.


The N-oxides may be prepared from the inventive compounds according to conventional oxidation methods, e. g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001). The oxidation may lead to pure mono-N-oxides or to a composition of different N-oxides, which can be separated by conventional methods such as chromatography.


If the synthesis yields compositions of isomers, a separation is generally not necessarily required since in some cases the individual isomers can be interconverted during work-up for use or during application (e. g. under the action of light, acids or bases). Such conversions may also take place after use, e. g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled.


In the compounds of the formula I according to the invention particular preference is given to the following meanings of the substituents, in each case on their own or in combination.


k in the compounds according to the invention is, according to one embodiment, 0. k in the compounds according to the invention is, according to one further embodiment, 1. k in the compounds according to the invention is, according to one further embodiment, 2.


l in the compounds according to the invention is, according to one embodiment, 0. l in the compounds according to the invention is, according to one further embodiment, 1. l in the compounds according to the invention is, according to one further embodiment, 2.


R1 in the compounds according to the invention is, according to one embodiment, H, OH, halogen, cyano, nitro. In a special embodiment of the invention, R1 is H. In a further special embodiment of the invention, R1 is OH. In a further special embodiment of the invention, R1 is CN. In a further special embodiment of the invention, R1 is nitro. In a further special embodiment of the invention, R1 is Cl or F.


R1 in the compounds according to the invention is, according to a further embodiment, C1-C10-alkyl, C1-C10-alkoxy, C1-C10-haloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C3-C10-cycloalkyl, C3-C10-halocycloalky or C3-C10-cycloalkenyl.


According to one embodiment R1 is C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C10-alkoxy, C1-C10-haloalkoxy, OA3, —C(═O)A4, —C(═O)OA4 in particular C2-C10-alkenyl, C2-C10-alkynyl, OA3, —C(═O)A4, wherein OA3, —C(═O)A4 are as defined below. In a special embodiment of the invention, R1 is methyl. In a further special embodiment of the invention, R1 is ethyl. In a further special embodiment of the invention, R1 is propyl. In a further special embodiment R1 is i-propyl. In a further special embodiment R1 is 1-methylpropyl. In a further special embodiment R1 is n-butyl. In a further special embodiment R1 is i-butyl. In a further special embodiment R1 is t-butyl. In a further special embodiment R1 is n-pentyl. In a further special embodiment R1 is n-hexyl.


According to a further embodiment R1 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular fully or partially halogenated methyl. In a special embodiment of the invention, R1 is CF3. In a further special embodiment of the invention, R1 is CHF2. In a further special embodiment R1 is CFH2. In a further special embodiment of the invention, R1 is CH2CF3. In a further special embodiment R1 is CCl3. In a further special embodiment R1 is CHCl2. In a further special embodiment R1 is CClH2.


According to a further embodiment R1 is C1-C10-alkoxy. In a special embodiment of the invention, R1 is OCH3. In a further special embodiment of the invention, R1 is OCH2CH3. In a further special embodiment of the invention, R1 is OCH2CH2CH3. In a further special embodiment of the invention, R1 is OCH(CH3)2. In a further special embodiment of the invention, R1 is OCH2CH2CH2CH3. In a further special embodiment of the invention, R1 is OCH(CH2CH3)2. In a further special embodiment of the invention, R1 is OC(CH3)3. In a further special embodiment of the invention, R1 is OCH2CH(CH3)2. In a further special embodiment of the invention, R1 is OCH2CH2CH2CH2CH3. In a further special embodiment of the invention, R1 is O CH2CH2CH2CH2CH2CH3.


According to a further embodiment R1 is C2-C10-alkenyl, preferably C2-C4-alkenyl. In a special embodiment of the invention, R1 is vinyl. In a special embodiment R1 is CH═CH2. In a further special embodiment R1 is CH2CH═CH2. In a further special embodiment R1 is CH2C(CH3)═CH2. In a further special embodiment R1 is CH2C(CH3)═CHCH3. In a further special embodiment R1 is CH2C(CH3)═C(CH3)2. In a further special embodiment R1 is CH2CH═CHCH3. In a further special embodiment R1 is CH═CHCH3. In a further special embodiment R1 is CH2C(CH3)═CH2.


According to a further embodiment R1 is C2-C10-alkynyl, preferably C2-C4-alkynyl. In a special embodiment of the invention, R1 is ethynyl. In a further special embodiment of the invention, R1 is 1-propynyl. In a further special embodiment of the invention, R1 is 2-propynyl. In a further special embodiment of the invention, R1 is 1-butynyl. In a further special embodiment of the invention, R1 is 3-methyl-but-1-ynyl.


According to a further embodiment R1 is C3-C10-cycloalkyl, preferably is C3-C6-cycloalkyl. In a special embodiment of the invention, R1 is cyclopropyl. In a further special embodiment of the invention, R1 is cyclopentyl.


According to a further embodiment R1 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl, cyclopentyl, in particular fully or partially halogenated cyclopropyl. In a further special embodiment R1 is 1-Cl-cyclopropyl. In a further special embodiment R1 is 2-Cl-cyclopropyl. In a further special embodiment R1 is 1-F-cyclopropyl. In a further special embodiment R1 is 2-F-cyclopropyl. In a further special embodiment R1 is fully or partially halogenated cyclobutyl. In a further special embodiment R1 is 1-Cl-cyclobutyl. In a further special embodiment R1 is 1-F-cyclobutyl. In a further special embodiment R1 is 2-Cl-cyclobutyl. In a further special embodiment R1 is 3-Cl-cyclobutyl. In a further special embodiment R1 is 2-F-cyclobutyl. In a further special embodiment R1 is 3-F-cyclobutyl. In a further special embodiment R1 is 3,3-(Cl)2-cyclobutyl. In a further special embodiment R1 is 3,3-(F)2-cyclobutyl. According to a further embodiment R1 is C3-C10-cycloalkenyl, preferably cyclopropenyl.


In a specific embodiment of the invention R1 is CH2CHO, CH2C(═O)OH, CH2C(═O NH2CH2C(═O)OC1-C10-alkyl, CH2C(═O)—NHC1-C10-alkyl, CH2C(═O)—N(C1-C10-alkyl)2, CH(C1-C4-alkyl)-CHO, CH(C1-C4-alkyl)-C(═O)OH, CH(C1-C4-alkyl)-C(═O)NH2CH(C1-C4-alkyl)-C(═O)OC1-C10-alkyl, CH(C1-C4-alkyl)-C(═O)NHC1-C10-alkyl, CH(C1-C4-alkyl)-C(═O)N(C1-C10-alkyl)2, C(C1-C4-alkyl)2-CHO, C(C1-C4-alkyl)2-C(═O)OH, C(C1-C4-alkyl)2-C(═O)NH2C(C1-C4-alkyl)2-C(═O)OC1-C10-alkyl, C(C1-C4-alkyl)2-C(═O)NHC1-C10-alkyl, C(C1-C4-alkyl)2-C(═O)N(C1-C10-alkyl)2R1 in the compounds according to the invention is, according to a further embodiment, phenyl, benzyl, naphthyl, a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment R1 is phenyl. According to a further embodiment R1 is benzyl. According to a further embodiment R1 is naphthyl. According to one embodiment R1 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members. In a special embodiment of the invention, R1 is phenyl or benzyl.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C10-alkoxy, C1-C10-haloalkoxy, are as defined below. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3.


In a special embodiment of the invention, R1 is phenyl. In a further special embodiment of the invention, R1 is phenyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3, especially 2,4-dichlorophenyl or 4-chlorophenyl. In a further special embodiment of the invention, R1 is benzyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R1 is naphthyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In the compounds according to the invention particular preference is given to the following meanings of the substituent R1, in each case on their own or in combination:

  • 2-chlorophenyl, 2-fluorophenyl, 2-methylphenyl, 2-trifluoromethylphenyl;
  • 3-chlorophenyl, 3-fluorophenyl, 3-methylphenyl, 3-trifluoromethylphenyl;
  • 4-chlorophenyl, 4-fluorophenyl, 4-methylphenyl, 4-trifluoromethylphenyl;
  • 2-chloro-4-fluorophenyl, 2,4-dichlorophenyl, 2,4-difluorophenyl, 2-fluoro-4-chlorophenyl;
  • 3-chloro-4-fluorophenyl, 3,4-dichlorophenyl, 3,4-difluorophenyl, 3-fluoro-4-chlorophenyl;
  • 3-fluoro-5-chlorophenyl or 3,5-difluorophenyl.


R1 in the compounds according to the invention is, according to a further embodiment, NA1A2 where A1 and A2 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C1-C10-alkoxy-C1-C10-alkyl, amino-C1-C10-alkyl; or independently of one another are phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A1 and A2 independently of one another are hydrogen. According to a further embodiment A1 and A2 independently of one another are hydrogen or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl. In a special embodiment of the invention, R1 is NH2, NHCH3, N(CH3)2, NHC2H5, NHn-C3H7, NHi-C3H7, NHn-Calls, NHi-C4H9, NHt-C4H9. According to a further embodiment A1 and A2 independently of one another are hydrogen or C3-C10-cycloalkyl, preferably cyclopropyl, cyclobutyl, cyclopenyl, cyclohexyl. In a special embodiment of the invention, R1 is cyclopropylamino, cyclobutylamino, cyclopentylamino, cyclohexylamino. According to a further embodiment A1 and A2 independently of one another are C1-C10-alkoxy-C1-C10-alkyl, preferably C1-C4-alkoxy-C1-C4-alkyl. In a special embodiment of the invention, R1 is methoxyethylamino, methoxypropylamino, methoxybutylamino, ethoxyethylamino, ethoxypropylamino or ethoxybutylamino. In a special embodiment of the invention, R1 is NH2. In a further special embodiment of the invention, R1 is N(CH3)2. In a further special embodiment of the invention, R1 is N(C2H5)2.


According to one embodiment A1 and A2 independently of one another are hydrogen or phenyl. According to one embodiment A1 and A2 independently of one another are hydrogen or benzyl. According to a further embodiment A1 and A2 independently of one another are hydrogen or naphthyl. According to a further embodiment A1 and A2 independently of one another are hydrogen or a saturated partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO, SO2 groups as ring members. In a special embodiment of the invention, R1 is NH2. In a further special embodiment of the invention, R1 is N(phenyl)2. In a further special embodiment of the invention, R1 is N(benzyl)2.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3. In a special embodiment of the invention, A1 and/or A2 are phenyl. In a further special embodiment of the invention, A1 and/or A2 are phenyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, A1 and/or A2 are benzyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, A1 and/or A2 are naphthyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3.


R1 in the compounds according to the invention is, according to a further embodiment, OA3, where A3 is hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment A3 is H or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl. In a special embodiment of the invention, R1 is OCH3, OC2H5, On-C3H7, Oi-C3H7, On-C4H9 or Oi-C4H9, Ot-C4H9. According to a further embodiment A3 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl, in particular fully or partially halogenated methyl. According to a further embodiment A3 is C2-C10-alkenyl, preferably ethylene. According to a further embodiment A3 is C2-C10-alkynyl, preferred ethynyl or 1-propynyl. According to a further embodiment A3 is C3-C10-cycloalkyl, preferrably cyclopropyl, cyclobutyl or cyclopentyl, in particular cyclopropyl or cyclobutyl. According to a further embodiment A3 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl or cyclopentyl, in particular fully or partially halogenated cyclopropyl. According to a further embodiment A3 is C3-C10-cycloalkenyl, preferably cyclopropenyl.


According to one embodiment A3 is phenyl. According to a further embodiment A3 is benzyl. According to a further embodiment A3 is naphthyl. According to one embodiment A3 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3. In a special embodiment of the invention, R1 is OPh, wherein phenyl can be substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3.


R1 in the compounds according to the invention is, according to a further embodiment, a radical of the formula —C(═O)A4, —C(═O)OA4, —OC(═O)A4, —NA4C(═O)A4, —NA4C(═O)OA4 -N═OA4 where A4 is hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A4 is H or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl. According to a further embodiment A4 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl, in particular fully or partially halogenated methyl. According to a further embodiment A4 is C2-C10-alkenyl, preferably ethylene. According to a further embodiment A4 is C2-C10-alkynyl, preferred ethynyl or 1-propynyl. According to a further embodiment A4 is C3-C10-cycloalkyl, preferrably cyclopropyl, cyclobutyl or cyclopentyl, in particular cyclopropyl or cyclobutyl. According to a further embodiment A4 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl or cyclopentyl, in particular fully or partially halogenated cyclopropyl. According to a further embodiment A4 is C3-C10-cycloalkenyl, preferably cyclopropenyl. According to a further embodiment A4 is NH2. According to a further embodiment A4 is mono-(C1-C10-alkyl)amino. According to a further embodiment A4 is di-(C1-C10-alkyl)amino.


According to one embodiment A4 is phenyl. According to a further embodiment A4 is benzyl. According to a further embodiment A4 is naphthyl. According to one embodiment A4 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3.


In a specific embodiment of the invention R1 is CHO, C(═O)OH, C(═O)NH2C(═O)OC1-C10-alkyl, C(═O)NHC1-C10-alkyl, C(═O)N(C1-C10-alkyl)2.


Further in a specific embodiment of the invention R1 is NH—C(═O)OH, NH—C(═O)NH2NH—C(═O)OC1-C10-alkyl, NH—C(═O)—NHC1-C10-alkyl, NH—C(═O)—N(C1-C10-alkyl)2, N(CH3)C(═O)OH, N(CH3)—C(═O)NH2N(CH3)—C(═O)OC1-C10-alkyl, N(CH3)—C(═O)—NHC1-C10-alkyl, N(CH3)—C(═O)—N(C1-C10-alkyl)2.


R1 in the compounds according to the invention is, according to a further embodiment, a radical of the formula —S(O)nA5, —OS(O)nA5, —NA5S(O)nA5 where n=0, 1, 2 and A5 independently of one another are hydrogen, hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated or unsaturated aromatic or non-aromatic 5-, 6-, 7-, 8, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A5 is H or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl. According to a further embodiment A5 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl, in particular fully or partially halogenated methyl. According to a further embodiment A5 is C2-C10-alkenyl, preferably ethylene. According to a further embodiment A5 is C2-C10-alkynyl, preferred ethynyl or 1-propynyl. According to a further embodiment A5 is C3-C10-cycloalkyl, preferrably cyclopropyl, cyclobutyl or cyclopentyl, in particular cyclopropyl or cyclobutyl. According to a further embodiment A5 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl or cyclopentyl, in particular fully or partially halogenated cyclopropyl. According to a further embodiment A5 is C3-C10-cycloalkenyl, preferably cyclopropenyl. According to a further embodiment A5 is NH2. According to a further embodiment A5 is mono-(C1-C10-alkyl)amino. According to a further embodiment A5 is di-(C1-C10-alkyl)amino.


In a specific embodiment of the invention R1 is SH and S—C1-C10-alkyl.


According to one embodiment A5 is phenyl. According to a further embodiment A5 is benzyl. According to a further embodiment A5 is naphthyl. According to one embodiment A5 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3.


R2 in the compounds according to the invention is, according to one embodiment, halogen, CN, NO2. In a further special embodiment of the invention, R2 is halogen such as Cl or F. In a further special embodiment of the invention, R2 is CN. In a further special embodiment of the invention, R2 is nitro.


R2 in the compounds according to the invention is, according to a further embodiment, NA2A2 where A2 and A2 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C1-C10-alkoxy-C1-C10-alkyl, amino-C1-C10-alkyl; or independently of one another are phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A2 and A2 independently of one another are hydrogen. According to a further embodiment A2 and A2 independently of one another are hydrogen or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl. In a special embodiment of the invention, R2 is NH2, NHCH3, N(CH3)2, NHC2H5, NHn-C3H7, NHi-C3H7, NHn-C4H9, NHi-C4H9, NHt-C4H9. According to a further embodiment A2 and A2 independently of one another are hydrogen or C3-C10-cycloalkyl, preferably cyclopropyl, cyclobutyl, cyclopenyl, cyclohexyl. In a special embodiment of the invention, R2 is cyclopropylamino, cyclobutylamino, cyclopentylamino, cyclohexylamino. According to a further embodiment A2 and A2 independently of one another are C1-C10-alkoxy-C1-C10-alkyl, preferably C1-C4-alkoxy-C1-C4-alkyl. In a special embodiment of the invention, R2 is methoxyethylamino, methoxypropylamino, methoxybutylamino, ethoxyethylamino, ethoxypropylamino or ethoxybutylamino. In a special embodiment of the invention, R2 is NH2. In a further special embodiment of the invention, R2 is N(CH3)2. In a further special embodiment of the invention, R2 is N(C2H5)2.


According to one embodiment A2 and A2 independently of one another are hydrogen or phenyl. According to one embodiment A2 and A2 independently of one another are hydrogen or benzyl. According to a further embodiment A2 and A2 independently of one another are hydrogen or naphthyl. According to a further embodiment A2 and A2 independently of one another are hydrogen or a saturated partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO, SO2 groups as ring members. In a special embodiment of the invention, R2 is NH2. In a further special embodiment of the invention, R2 is N(phenyl)2. In a further special embodiment of the invention, R2 is N(benzyl)2.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3. In a special embodiment of the invention, A2 and/or A2 are phenyl. In a further special embodiment of the invention, A2 and/or A2 are phenyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, A2 and/or A2 are benzyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, A2 and/or A2 are naphthyl substituted by Cl, F, Br, I, CH3, OCH3, CF3 or OCF3.


R2 in the compounds according to the invention is, according to a further embodiment, a radical of the formula —C(═O)A4, —OC(═O)A4, —NA4C(═O)A4, —N═OA4 where A4 is hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A4 is H or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl. According to a further embodiment A4 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl, in particular fully or partially halogenated methyl. According to a further embodiment A4 is C2-C10-alkenyl, preferably ethylene. According to a further embodiment A4 is C2-C10-alkynyl, preferred ethynyl or 1-propynyl. According to a further embodiment A4 is C3-C10-cycloalkyl, preferrably cyclopropyl, cyclobutyl or cyclopentyl, in particular cyclopropyl or cyclobutyl. According to a further embodiment A4 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl or cyclopentyl, in particular fully or partially halogenated cyclopropyl. According to a further embodiment A4 is C3-C10-cycloalkenyl, preferably cyclopropenyl. According to a further embodiment A4 is NH2. According to a further embodiment A4 is mono-(C1-C10-alkyl)amino. According to a further embodiment A4 is di-(C1-C10-alkyl)amino.


In a special embodiment of the invention, R2 is —C(═O)CH3. In a further special embodiment of the invention, R2 is —C(═O)CH2CH3. In a further special embodiment of the invention, R2 is —C(═O)CH(CH3)2. In a further special embodiment of the invention, R2 is —C(═O)C(CH3)3. In a further special embodiment of the invention, R2 is —C(═O)OH. In a further special embodiment of the invention, R2 is —C(═O)OCH3. In a further special embodiment of the invention, R2 is —C(═O)OCH2CH3. In a further special embodiment of the invention, R2 is —C(═O)OCH(CH3)2. In a further special embodiment of the invention, R2 is —C(═O)OC(CH3)3. In a further special embodiment of the invention, R2 is —C(═O)NH2. In a further special embodiment of the invention, R2 is —C(═O)NHCH3. In a further special embodiment of the invention, R2 is —C(═O)NHCH2CH3. In a further special embodiment of the invention, R2 is —C(═O)NHCH(CH3)2. In a further special embodiment of the invention, R2 is —C(═O)NHC(CH3)3. In a further special embodiment of the invention, R2 is —C(═O)N(CH3)2. In a further special embodiment of the invention, R2 is —C(═O)N(CH2CH3)2. In a further special embodiment of the invention, R2 is —C(═O)N(CH(CH3)2)2. In a further special embodiment of the invention, R2 is —C(═O)N(C(CH3)3)2.


According to one embodiment A4 is phenyl. According to a further embodiment A4 is benzyl. According to a further embodiment A4 is naphthyl. According to one embodiment A4 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3.


R2 in the compounds according to the invention is, according to a further embodiment, a radical of the formula —S(O)nA5, —OS(O)nA5, —NA5S(O)nA5 where n=0, 1, 2 and A5 independently of one another are hydrogen, hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, NH2, mono-(C1-C10-alkyl)amino, di-(C1-C10-alkyl)amino, phenyl, benzyl, naphthyl or a saturated or unsaturated aromatic or non-aromatic 5-, 6-, 7-, 8, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO groups as ring members, wherein the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of halogen, hydroxyl, cyano, nitro, NH2, C1-C10-alkyl, C1-C10-haloalkyl, C1-C10-alkoxy, C1-C10-haloalkoxy.


According to one embodiment A5 is H or C1-C10-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl. According to a further embodiment A5 is C1-C10-haloalkyl; preferrably fully or partially halogenated methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl or t-butyl, in particular fully or partially halogenated methyl. According to a further embodiment A5 is C2-C10-alkenyl, preferably ethylene. According to a further embodiment A5 is C2-C10-alkynyl, preferred ethynyl or 1-propynyl. According to a further embodiment A5 is C3-C10-cycloalkyl, preferrably cyclopropyl, cyclobutyl or cyclopentyl, in particular cyclopropyl or cyclobutyl. According to a further embodiment A5 is C3-C10-halocycloalkyl, preferrably fully or partially halogenated cyclopropyl, cyclobutyl or cyclopentyl, in particular fully or partially halogenated cyclopropyl. According to a further embodiment A5 is C3-C10-cycloalkenyl, preferably cyclopropenyl. According to a further embodiment A5 is NH2. According to a further embodiment A5 is mono-(C1-C10-alkyl)amino. According to a further embodiment A5 is di-(C1-C10-alkyl)amino.


According to one embodiment A5 is phenyl. According to a further embodiment A5 is benzyl. According to a further embodiment A5 is naphthyl. According to one embodiment A5 is a saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle, where the heterocycle contains 1, 2, 3 or 4 heteroatoms selected from the group consisting of O, N and S as ring members and may furthermore contain one or two CO, SO or SO2 groups as ring members.


According to one embodiment phenyl, benzyl, naphthyl and the saturated, partially unsaturated or aromatic 5-, 6-, 7-, 8-, 9- or 10-membered heterocycle may carry one, two, three or four identical or different substituents selected from the group consisting of Cl, I, F, Br, preferably Cl, F. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3.


In a special embodiment of the invention, R2 is —SCH3. In a further special embodiment of the invention, R2 is —S(O)2CH3.


According to one embodiment, the present invention relates to compounds of the formula I.A




embedded image


Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.


According to one embodiment, the present invention relates to compounds of the formula I.B




embedded image


Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.


According to one embodiment, the present invention relates to compounds of the formula I.C




embedded image


Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.


According to one embodiment, the present invention relates to compounds of the formula I.D




embedded image


Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.


According to one embodiment, the present invention relates to compounds of the formula I.E




embedded image


Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.


Preference is given to the compounds I according to the invention compiled in Tables 1a to 42a, 1b to 42b, 1c to 42c, 1d to 42d, 1e to 42e below with the proviso as defined above. The groups mentioned for a substituent in the tables are furthermore per se, independently of the combination in which they are mentioned, a particularly preferred aspect of the substituent in question.


Table 1a


Compounds of the formula I.A in which R1 corresponds to line A-1 of Table A and the meaning R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A1.B1 to I.A.A1.B21B21).


Table 2a


Compounds of the formula I.A in which R1 corresponds to line A-2 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A2.B1 to I.A.A2.B21B21).


Table 3a


Compounds of the formula I.A in which R1 corresponds to line A-3 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A3.B1 to I.A.A3.B21B21).


Table 4a


Compounds of the formula I.A in which R1 corresponds to line A-4 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A4.B1 to I.A.A4.B21B21).


Table 5a


Compounds of the formula I.A in which R1 corresponds to line A-5 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A5.B1 to I.A.A5.B21B21).


Table 6a


Compounds of the formula I.A in which R1 corresponds to line A-6 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A6.B1 to I.A.A6.B21B21).


Table 7a


Compounds of the formula I.A in which R1 corresponds to line A-7 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A7.B1 to I.A.A7.B21B21).


Table 8a


Compounds of the formula I.A in which R1 corresponds to line A-8 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A8.B1 to I.A.A8.B21B21).


Table 9a


Compounds of the formula I.A in which R1 corresponds to line A-9 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A9.B1 to I.A.A9.B21B21).


Table 10a


Compounds of the formula I.A in which R1 corresponds to line A-10 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A10.B1 to I.A.A10.B21B21).


Table 11a


Compounds of the formula I.A in which R1 corresponds to line A-11 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A11.B1 to I.A.A11.B21.B21).


Table 12a


Compounds of the formula I.A in which R1 corresponds to line A-12 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A12.B1 to I.A.A12.B21.B21).


Table 13a


Compounds of the formula I.A in which R1 corresponds to line A-13 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A13.B1 to I.A.A13.B21.B21).


Table 14a


Compounds of the formula I.A in which R1 corresponds to line A-14 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A14.B1 to I.A.A14.B21.B21).


Table 15a


Compounds of the formula I.A in which R1 corresponds to line A-15 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A15.B1 to I.A.A15.B21).


Table 16a


Compounds of the formula I.A in which R1 corresponds to line A-16 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A16.B1 to I.A.A16.B21).


Table 17a


Compounds of the formula I.A in which R1 corresponds to line A-17 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A17.B1 to I.A.A17.B21).


Table 18a


Compounds of the formula I.A in which R1 corresponds to line A-18 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A18.B1 to I.A.A18.B21).


Table 19a


Compounds of the formula I.A in which R1 corresponds to line A-19 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A19.B1 to I.A.A19.B21).


Table 20a


Compounds of the formula I.A in which R1 corresponds to line A-20 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A20.B1 to I.A.A20.B21).


Table 21a


Compounds of the formula I.A in which R1 corresponds to line A-21 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A21.B1 to I.A.A21.B21).


Table 22a


Compounds of the formula I.A in which R1 corresponds to line A-22 of Table A and the meaning for the combination of (R4)m and R32 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A22.B1 to I.A.A22.B21).


Table 23a


Compounds of the formula I.A in which R1 corresponds to line A-23 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A23.B1 to I.A.A23.B21).


Table 24a


Compounds of the formula I.A in which R1 corresponds to line A-24 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A24.B1 to I.A.A24.B21).


Table 25a


Compounds of the formula I.A in which R1 corresponds to line A-25 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A25.B1 to I.A.A25.B21).


Table 26a


Compounds of the formula I.A in which R1 corresponds to line A-26 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A26.B1 to I.A.A26.B21).


Table 27a


Compounds of the formula I.A in which R1 corresponds to line A-27 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A27.B1 to I.A.A27.B21).


Table 28a


Compounds of the formula I.A in which R1 corresponds to line A-28 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A28.B1 to I.A.A28.B21).


Table 29a


Compounds of the formula I.A in which R1 corresponds to line A-29 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A29.B1 to I.A.A29.B21).


Table 30a


Compounds of the formula I.A in which R1 corresponds to line A-30 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A30.B1 to I.A.A30.B21).


Table 31a


Compounds of the formula I.A in which R1 corresponds to line A-31 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A31.B1 to I.A.A31.B21).


Table 32a


Compounds of the formula I.A in which R1 corresponds to line A-32 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A32.B1 to I.A.A32.B21).


Table 33a


Compounds of the formula I.A in which R1 corresponds to line A-33 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A33.B1 to I.A.A33.B21).


Table 34a


Compounds of the formula I.A in which R1 corresponds to line A-34 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A34.B1 to I.A.A34.B21).


Table 35a


Compounds of the formula I.A in which R1 corresponds to line A-35 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A35.B1 to I.A.A35.B21).


Table 36a


Compounds of the formula I.A in which R1 corresponds to line A-36 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A36.B1 to I.A.A36.B21).


Table 37a


Compounds of the formula I.A in which R1 corresponds to line A-37 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A37.B1 to I.A.A37.B21).


Table 38a


Compounds of the formula I.A in which R1 corresponds to line A-38 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A38.B1 to I.A.A38.B21).


Table 39a


Compounds of the formula I.A in which R1 corresponds to line A-39 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A39.B1 to I.A.A39.B21).


Table 40a


Compounds of the formula I.A in which R1 corresponds to line A-40 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A40.B1 to I.A.A40.B21).


Table 41a


Compounds of the formula I.A in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A41.B1 to I.A.A41.B21).


Table 42a


Compounds of the formula I.A in which R1 corresponds to line A-42 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A42.B1 to I.A.A42.B21).


Table 43a


Compounds of the formula I.A in which R1 corresponds to line A-43 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A43.B1 to I.A.A43.B21).


Table 44a


Compounds of the formula I.A in which R1 corresponds to line A-44 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A44.B1 to I.A.A44.B21).


Table 45a


Compounds of the formula I.A in which R1 corresponds to line A-45 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A45.B1 to I.A.A45.B21).


Table 46a


Compounds of the formula I.A in which R1 corresponds to line A-46 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A46.B1 to I.A.A46.B21).


Table 47a


Compounds of the formula I.A in which R1 corresponds to line A-47 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A47.B1 to I.A.A47.B21).


Table 48a


Compounds of the formula I.A in which R1 corresponds to line A-48 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A48.B1 to I.A.A48.B21).


Table 49a


Compounds of the formula I.A in which R1 corresponds to line A-49 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A49.B1 to I.A.A49.B21).


Table 50a


Compounds of the formula I.A in which R1 corresponds to line A-50 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A50.B1 to I.A.A50.B21).


Table 51a


Compounds of the formula I.A in which R1 corresponds to line A-51 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A51.B1 to I.A.A51.B21).


Table 52a


Compounds of the formula I.A in which R1 corresponds to line A-52 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A52.B1 to I.A.A52.B21).


Table 53a


Compounds of the formula I.A in which R1 corresponds to line A-53 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A53.B1 to I.A.A53.B21).


Table 54a


Compounds of the formula I.A in which R1 corresponds to line A-54 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A54.B1 to I.A.A54.B21).


Table 55a


Compounds of the formula I.A in which R1 corresponds to line A-55 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A55.B1 to I.A.A55.B21).


Table 56a


Compounds of the formula I.A in which R1 corresponds to line A-56 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A56.B1 to I.A.A56.B21).


Table 57a


Compounds of the formula I.A in which R1 corresponds to line A-57 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A57.B1 to I.A.A57.B21).


Table 58a


Compounds of the formula I.A in which R1 corresponds to line A-58 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A58.B1 to I.A.A58.B21).


Table 59a


Compounds of the formula I.A in which R1 corresponds to line A-59 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A59.B1 to I.A.A59.B21).


Table 60a


Compounds of the formula I.A in which R1 corresponds to line A-60 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A60.B1 to I.A.A60.B21).


Table 61a


Compounds of the formula I.A in which R1 corresponds to line A-61 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A61.B1 to I.A.A61.B21).


Table 62a


Compounds of the formula I.A in which R1 corresponds to line A-62 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A62.B1 to I.A.A62.B21).


Table 63a


Compounds of the formula I.A in which R1 corresponds to line A-63 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A63.B1 to I.A.A63.B21).


Table 64a


Compounds of the formula I.A in which R1 corresponds to line A-64 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A64.B1 to I.A.A64.B21).


Table 65a


Compounds of the formula I.A in which R1 corresponds to line A-65 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A65.B1 to I.A.A65.B21).


Table 66a


Compounds of the formula I.A in which R1 corresponds to line A-66 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A66.B1 to I.A.A66.B21).


Table 67a


Compounds of the formula I.A in which R1 corresponds to line A-67 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A67.B1 to I.A.A67.B21).


Table 68a


Compounds of the formula I.A in which R1 corresponds to line A-68 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A68.B1 to I.A.A68.B21).


Table 69a


Compounds of the formula I.A in which R1 corresponds to line A-69 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A69.B1 to I.A.A69.B21).


Table 70a


Compounds of the formula I.A in which R1 corresponds to line A-70 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A70.B1 to I.A.A70.B21).


Table 71a


Compounds of the formula I.A in which R1 corresponds to line A-71 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A71.B1 to I.A.A71.B21).


Table 72a


Compounds of the formula I.A in which R1 corresponds to line A-72 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A72.B1 to I.A.A72.B21).


Table 73a


Compounds of the formula I.A in which R1 corresponds to line A-73 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A73.B1 to I.A.A73.B21).


Table 74a


Compounds of the formula I.A in which R1 corresponds to line A-74 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A74.B1 to I.A.A74B21).


Table 75a


Compounds of the formula I.A in which R1 corresponds to line A-75 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A75.B1 to I.A.A75.B21).


Table 76a


Compounds of the formula I.A in which R1 corresponds to line A-76 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A76.B1 to I.A.A76.B21).


Table 77a


Compounds of the formula I.A in which R1 corresponds to line A-77 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A77.B1 to I.A.A77.B21).


Table 78a


Compounds of the formula I.A in which R1 corresponds to line A-78 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A78.B1 to I.A.A78.B21).


Table 79a


Compounds of the formula I.A in which R1 corresponds to line A-79 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A79.B1 to I.A.A79.B21).


Table 80a


Compounds of the formula I.A in which R1 corresponds to line A-80 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A80.B1 to I.A.A80.B21).


Table 81a


Compounds of the formula I.A in which R1 corresponds to line A-81 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A81.B1 to I.A.A81.B21).


Table 82a


Compounds of the formula I.A in which R1 corresponds to line A-82 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A82.B1 to I.A.A82.B21).


Table 83a


Compounds of the formula I.A in which R1 corresponds to line A-83 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A83.B1 to I.A.A83.B21).


Table 84a


Compounds of the formula I.A in which R1 corresponds to line A-84 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A84.B1 to I.A.A84.B21).


Table 85a


Compounds of the formula I.A in which R1 corresponds to line A-85 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A85.B1 to I.A.A85.B21).


Table 86a


Compounds of the formula I.A in which R1 corresponds to line A-86 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A86.B1 to I.A.A86.B21).


Table 87a


Compounds of the formula I.A in which R1 corresponds to line A-87 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A87.B1 to I.A.A87.B21).


Table 88a


Compounds of the formula I.A in which R1 corresponds to line A-88 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A88.B1 to I.A.A88.B21).


Table 89a


Compounds of the formula I.A in which R1 corresponds to line A-89 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A89.B1 to I.A.A89.B21).


Table 90a


Compounds of the formula I.A in which R1 corresponds to line A-90 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A90.B1 to I.A.A90.B21).


Table 91a


Compounds of the formula I.A in which R1 corresponds to line A-91 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A91.B1 to I.A.A91.B21).


Table 92a


Compounds of the formula I.A in which R1 corresponds to line A-92 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A92.B1 to I.A.A92.B21).


Table 93a


Compounds of the formula I.A in which R1 corresponds to line A-93 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A93.B1 to I.A.A93.B21).


Table 94a


Compounds of the formula I.A in which R1 corresponds to line A-94 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A94.B1 to I.A.A94.B21).


Table 95a


Compounds of the formula I.A in which R1 corresponds to line A-95 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A95.B1 to I.A.A95.B21).


Table 96a


Compounds of the formula I.A in which R1 corresponds to line A-96 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A96.B1 to I.A.A96.B21).


Table 97a


Compounds of the formula I.A in which R1 corresponds to line A-97 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A97.B1 to I.A.A97.B21).


Table 98a


Compounds of the formula I.A in which R1 corresponds to line A-98 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A98.B1 to I.A.A98.B21).


Table 99a


Compounds of the formula I.A in which R1 corresponds to line A-99 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A99.B1 to I.A.A99.B21).


Table 100a


Compounds of the formula I.A in which R1 corresponds to line A-100 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A100.B1 to I.A.A100.B21).


Table 101a


Compounds of the formula I.A in which R1 corresponds to line A-101 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.A.A101.B1 to I.A.A101.B21).


Table 1b


Compounds of the formula I.B in which R1 corresponds to line A-1 of Table A and the meaning R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A1.B1 to I.B.A1.B21).


Table 2b


Compounds of the formula I.B in which R1 corresponds to line A-2 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A2.B1 to I.B.A2.B21).


Table 3b


Compounds of the formula I.B in which R1 corresponds to line A-3 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A3.B1 to I.B.A3.B21).


Table 4b


Compounds of the formula I.B in which R1 corresponds to line A-4 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A4.B1 to I.B.A4.B21).


Table 5b


Compounds of the formula I.B in which R1 corresponds to line A-5 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A5.B1 to I.B.A5.B21).


Table 6b


Compounds of the formula I.B in which R1 corresponds to line A-6 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A6.B1 to I.B.A6.B21).


Table 7b


Compounds of the formula I.B in which R1 corresponds to line A-7 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A7.B1 to I.B.A7.B21).


Table 8b


Compounds of the formula I.B in which R1 corresponds to line A-8 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A8.B1 to I.B.A8.B21).


Table 9b


Compounds of the formula I.B in which R1 corresponds to line A-9 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A9.B1 to I.B.A9.B21).


Table 10b


Compounds of the formula I.B in which R1 corresponds to line A-10 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A10.B1 to I.B.A10.B21).


Table 11 b


Compounds of the formula I.B in which R1 corresponds to line A-11 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A11.B1 to I.B.A11.B21).


Table 12b


Compounds of the formula I.B in which R1 corresponds to line A-12 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A12.B1 to I.B.A12.B21).


Table 13b


Compounds of the formula I.B in which R1 corresponds to line A-13 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A13.B1 to I.B.A13.B21).


Table 14b


Compounds of the formula I.B in which R1 corresponds to line A-14 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A14.B1 to I.B.A14.B21).


Table 15b


Compounds of the formula I.B in which R1 corresponds to line A-15 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A15.B1 to I.B.A15.B21).


Table 16b


Compounds of the formula I.B in which R1 corresponds to line A-16 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A16.B1 to I.B.A16.B21).


Table 17b


Compounds of the formula I.B in which R1 corresponds to line A-17 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A17.B1 to I.B.A17.B21).


Table 18b


Compounds of the formula I.B in which R1 corresponds to line A-18 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A18.B1 to I.B.A18.B21).


Table 19b


Compounds of the formula I.B in which R1 corresponds to line A-19 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A19.B1 to I.B.A19.B21).


Table 20b


Compounds of the formula I.B in which R1 corresponds to line A-20 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A20.B1 to I.B.A20.B21).


Table 21b


Compounds of the formula I.B in which R1 corresponds to line A-21 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A21.B1 to I.B.A21.B21).


Table 22b


Compounds of the formula I.B in which R1 corresponds to line A-22 of Table A and the meaning for the combination of (R4)m and R32 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A22.B1 to I.B.A22.B21).


Table 23b


Compounds of the formula I.B in which R1 corresponds to line A-23 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A23.B1 to I.B.A23.B21).


Table 24b


Compounds of the formula I.B in which R1 corresponds to line A-24 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A24.B1 to I.B.A24.B21).


Table 25b


Compounds of the formula I.B in which R1 corresponds to line A-25 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A25.B1 to I.B.A25.B21).


Table 26b


Compounds of the formula I.B in which R1 corresponds to line A-26 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A26.B1 to I.B.A26.B21).


Table 27b


Compounds of the formula I.B in which R1 corresponds to line A-27 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A27.B1 to I.B.A27.B21).


Table 28b


Compounds of the formula I.B in which R1 corresponds to line A-28 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A28.B1 to I.B.A28.B21).


Table 29b


Compounds of the formula I.B in which R1 corresponds to line A-29 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A29.B1 to I.B.A29.B21).


Table 30b


Compounds of the formula I.B in which R1 corresponds to line A-30 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A30.B1 to I.B.A30.B21).


Table 31b


Compounds of the formula I.B in which R1 corresponds to line A-31 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A31.B1 to I.B.A31.B21).


Table 32b


Compounds of the formula I.B in which R1 corresponds to line A-32 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A32.B1 to I.B.A32.B21).


Table 33b


Compounds of the formula I.B in which R1 corresponds to line A-33 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A33.B1 to I.B.A33.B21).


Table 34b


Compounds of the formula I.B in which R1 corresponds to line A-34 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A34.B1 to I.B.A34.B21).


Table 35b


Compounds of the formula I.B in which R1 corresponds to line A-35 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A35.B1 to I.B.A35.B21).


Table 36b


Compounds of the formula I.B in which R1 corresponds to line A-36 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A36.B1 to I.B.A36.B21).


Table 37b


Compounds of the formula I.B in which R1 corresponds to line A-37 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A37.B1 to I.B.A37.B21).


Table 38b


Compounds of the formula I.B in which R1 corresponds to line A-38 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A38.B1 to I.B.A38.B21).


Table 39b


Compounds of the formula I.B in which R1 corresponds to line A-39 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A39.B1 to I.B.A39.B21).


Table 40b


Compounds of the formula I.B in which R1 corresponds to line A-40 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A40.B1 to I.B.A40.B21).


Table 41b


Compounds of the formula I.B in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A41.B1 to I.B.A41.B21).


Table 42b


Compounds of the formula I.B in which R1 corresponds to line A-42 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A42.B1 to I.B.A42.B21).


Table 43b


Compounds of the formula I.B in which R1 corresponds to line A-43 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A43.B1 to I.B.A43.B21).


Table 44b


Compounds of the formula I.B in which R1 corresponds to line A-44 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A44.B1 to I.B.A44.B21).


Table 45b


Compounds of the formula I.B in which R1 corresponds to line A-45 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A45.B1 to I.B.A45.B21).


Table 46b


Compounds of the formula I.B in which R1 corresponds to line A-46 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A46.B1 to I.B.A46.B21).


Table 47b


Compounds of the formula I.B in which R1 corresponds to line A-47 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A47.B1 to I.B.A47.B21).


Table 48b


Compounds of the formula I.B in which R1 corresponds to line A-48 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A48.B1 to I.B.A48.B21).


Table 49b


Compounds of the formula I.B in which R1 corresponds to line A-49 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A49.B1 to I.B.A49.B21).


Table 50b


Compounds of the formula I.B in which R1 corresponds to line A-50 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A50.B1 to I.B.A50.B21).


Table 51b


Compounds of the formula I.B in which R1 corresponds to line A-51 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A51.B1 to I.B.A51.B21).


Table 52b


Compounds of the formula I.B in which R1 corresponds to line A-52 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A52.B1 to I.B.A52.B21).


Table 53b


Compounds of the formula I.B in which R1 corresponds to line A-53 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A53.B1 to I.B.A53.B21).


Table 54b


Compounds of the formula I.B in which R1 corresponds to line A-54 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A54.B1 to I.B.A54.B21).


Table 55b


Compounds of the formula I.B in which R1 corresponds to line A-55 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A55.B1 to I.B.A55.B21).


Table 56b


Compounds of the formula I.B in which R1 corresponds to line A-56 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A56.B1 to I.B.A56.B21).


Table 57b


Compounds of the formula I.B in which R1 corresponds to line A-57 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A57.B1 to I.B.A57.B21).


Table 58b


Compounds of the formula I.B in which R1 corresponds to line A-58 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A58.B1 to I.B.A58.B21).


Table 59b


Compounds of the formula I.B in which R1 corresponds to line A-59 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A59.B1 to I.B.A59.B21).


Table 60b


Compounds of the formula I.B in which R1 corresponds to line A-60 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A60.B1 to I.B.A60.B21).


Table 61b


Compounds of the formula I.B in which R1 corresponds to line A-61 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A61.B1 to I.B.A61.B21).


Table 62b


Compounds of the formula I.B in which R1 corresponds to line A-62 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A62.B1 to I.B.A62.B21).


Table 63b


Compounds of the formula I.B in which R1 corresponds to line A-63 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A63.B1 to I.B.A63.B21).


Table 64b


Compounds of the formula I.B in which R1 corresponds to line A-64 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A64.B1 to I.B.A64.B21).


Table 65b


Compounds of the formula I.B in which R1 corresponds to line A-65 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A65.B1 to I.B.A65.B21).


Table 66b


Compounds of the formula I.B in which R1 corresponds to line A-66 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A66.B1 to I.B.A66.B21).


Table 67b


Compounds of the formula I.B in which R1 corresponds to line A-67 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A67.B1 to I.B.A67.B21).


Table 68b


Compounds of the formula I.B in which R1 corresponds to line A-68 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A68.B1 to I.B.A68.B21).


Table 69b


Compounds of the formula I.B in which R1 corresponds to line A-69 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A69.B1 to I.B.A69.B21).


Table 70b


Compounds of the formula I.B in which R1 corresponds to line A-70 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A70.B1 to I.B.A70.B21).


Table 71b


Compounds of the formula I.B in which R1 corresponds to line A-71 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A71.B1 to I.B.A71.B21).


Table 72b


Compounds of the formula I.B in which R1 corresponds to line A-72 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A72.B1 to I.B.A72.B21).


Table 73b


Compounds of the formula I.B in which R1 corresponds to line A-73 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A73.B1 to I.B.A73.B21).


Table 74b


Compounds of the formula I.B in which R1 corresponds to line A-74 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A74.B1 to I.B.A74B21).


Table 75b


Compounds of the formula I.B in which R1 corresponds to line A-75 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A75.B1 to I.B.A75.B21).


Table 76b


Compounds of the formula I.B in which R1 corresponds to line A-76 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A76.B1 to I.B.A76.B21).


Table 77b


Compounds of the formula I.B in which R1 corresponds to line A-77 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A77.B1 to I.B.A77.B21).


Table 78b


Compounds of the formula I.B in which R1 corresponds to line A-78 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A78.B1 to I.B.A78.B21).


Table 79b


Compounds of the formula I.B in which R1 corresponds to line A-79 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A79.B1 to I.B.A79.B21).


Table 80b


Compounds of the formula I.B in which R1 corresponds to line A-80 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A80.B1 to I.B.A80.B21).


Table 81b


Compounds of the formula I.B in which R1 corresponds to line A-81 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A81.B1 to I.B.A81.B21).


Table 82b


Compounds of the formula I.B in which R1 corresponds to line A-82 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A82.B1 to I.B.A82.B21).


Table 83b


Compounds of the formula I.B in which R1 corresponds to line A-83 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A83.B1 to I.B.A83.B21).


Table 84b


Compounds of the formula I.B in which R1 corresponds to line A-84 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A84.B1 to I.B.A84.B21).


Table 85b


Compounds of the formula I.B in which R1 corresponds to line A-85 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A85.B1 to I.B.A85.B21).


Table 86b


Compounds of the formula I.B in which R1 corresponds to line A-86 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A86.B1 to I.B.A86.B21).


Table 87b


Compounds of the formula I.B in which R1 corresponds to line A-87 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A87.B1 to I.B.A87.B21).


Table 88b


Compounds of the formula I.B in which R1 corresponds to line A-88 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A88.B1 to I.B.A88.B21).


Table 89b


Compounds of the formula I.B in which R1 corresponds to line A-89 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A89.B1 to I.B.A89.B21).


Table 90b


Compounds of the formula I.B in which R1 corresponds to line A-90 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A90.B1 to I.B.A90.B21).


Table 91b


Compounds of the formula I.B in which R1 corresponds to line A-91 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A91.B1 to I.B.A91.B21).


Table 92b


Compounds of the formula I.B in which R1 corresponds to line A-92 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A92.B1 to I.B.A92.B21).


Table 93b


Compounds of the formula I.B in which R1 corresponds to line A-93 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A93.B1 to I.B.A93.B21).


Table 94b


Compounds of the formula I.B in which R1 corresponds to line A-94 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A94.B1 to I.B.A94.B21).


Table 95b


Compounds of the formula I.B in which R1 corresponds to line A-95 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A95.B1 to I.B.A95.B21).


Table 96b


Compounds of the formula I.B in which R1 corresponds to line A-96 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A96.B1 to I.B.A96.B21).


Table 97b


Compounds of the formula I.B in which R1 corresponds to line A-97 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A97.B1 to I.B.A97.B21).


Table 98b


Compounds of the formula I.B in which R1 corresponds to line A-98 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A98.B1 to I.B.A98.B21).


Table 99b


Compounds of the formula I.B in which R1 corresponds to line A-99 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A99.B1 to I.B.A99.B21).


Table 100b


Compounds of the formula I.B in which R1 corresponds to line A-100 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A100.B1 to I.B.A100.B21).


Table 101b


Compounds of the formula I.B in which R1 corresponds to line A-101 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.B.A101.B1 to I.B.A101.B21).


Table 102b


Table 1c


Compounds of the formula I.C in which R1 corresponds to line A-1 of Table A and the meaning R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A1.B1 to I.C.A1.B21).


Table 2c


Compounds of the formula I.C in which R1 corresponds to line A-2 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A2.B1 to I.C.A2.B21).


Table 3c


Compounds of the formula I.C in which R1 corresponds to line A-3 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A3.B1 to I.C.A3.B21).


Table 4c


Compounds of the formula I.C in which R1 corresponds to line A-4 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A4.B1 to I.C.A4.B21).


Table 5c


Compounds of the formula I.C in which R1 corresponds to line A-5 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A5.B1 to I.C.A5.B21).


Table 6c


Compounds of the formula I.C in which R1 corresponds to line A-6 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A6.B1 to I.C.A6.B21).


Table 7c


Compounds of the formula I.C in which R1 corresponds to line A-7 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A7.B1 to I.C.A7.B21).


Table 8c


Compounds of the formula I.C in which R1 corresponds to line A-8 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A8.B1 to I.C.A8.B21).


Table 9c


Compounds of the formula I.C in which R1 corresponds to line A-9 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A9.B1 to I.C.A9.B21).


Table 10c


Compounds of the formula I.C in which R1 corresponds to line A-10 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A10.B1 to I.C.A10.B21).


Table 11c


Compounds of the formula I.C in which R1 corresponds to line A-11 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A11.B1 to I.C.A11.B21).


Table 12c


Compounds of the formula I.C in which R1 corresponds to line A-12 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A12.B1 to I.C.A12.B21).


Table 13c


Compounds of the formula I.C in which R1 corresponds to line A-13 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A13.B1 to I.C.A13.B21).


Table 14c


Compounds of the formula I.C in which R1 corresponds to line A-14 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A14.B1 to I.C.A14.B21).


Table 15c


Compounds of the formula I.C in which R1 corresponds to line A-15 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A15.B1 to I.C.A15.B21).


Table 16c


Compounds of the formula I.C in which R1 corresponds to line A-16 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A16.B1 to I.C.A16.B21).


Table 17c


Compounds of the formula I.C in which R1 corresponds to line A-17 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A17.B1 to I.C.A17.B21).


Table 18c


Compounds of the formula I.C in which R1 corresponds to line A-18 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A18.B1 to I.C.A18.B21).


Table 19c


Compounds of the formula I.C in which R1 corresponds to line A-19 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A19.B1 to I.C.A19.B21).


Table 20c


Compounds of the formula I.C in which R1 corresponds to line A-20 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A20.B1 to I.C.A20.B21).


Table 21c


Compounds of the formula I.C in which R1 corresponds to line A-21 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A21.B1 to I.C.A21.B21).


Table 22c


Compounds of the formula I.C in which R1 corresponds to line A-22 of Table A and the meaning for the combination of (R4)m and R32 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A22.B1 to I.C.A22.B21).


Table 23c


Compounds of the formula I.C in which R1 corresponds to line A-23 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A23.B1 to I.C.A23.B21).


Table 24c


Compounds of the formula I.C in which R1 corresponds to line A-24 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A24.B1 to I.C.A24.B21).


Table 25c


Compounds of the formula I.C in which R1 corresponds to line A-25 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A25.B1 to I.C.A25.B21).


Table 26c


Compounds of the formula I.C in which R1 corresponds to line A-26 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A26.B1 to I.C.A26.B21).


Table 27c


Compounds of the formula I.C in which R1 corresponds to line A-27 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A27.B1 to I.C.A27.B21).


Table 28c


Compounds of the formula I.C in which R1 corresponds to line A-28 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A28.B1 to I.C.A28.B21).


Table 29c


Compounds of the formula I.C in which R1 corresponds to line A-29 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A29.B1 to I.C.A29.B21).


Table 30c


Compounds of the formula I.C in which R1 corresponds to line A-30 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A30.B1 to I.C.A30.B21).


Table 31c


Compounds of the formula I.C in which R1 corresponds to line A-31 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A31.B1 to I.C.A31.B21).


Table 32c


Compounds of the formula I.C in which R1 corresponds to line A-32 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A32.B1 to I.C.A32.B21).


Table 33c


Compounds of the formula I.C in which R1 corresponds to line A-33 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A33.B1 to I.C.A33.B21).


Table 34c


Compounds of the formula I.C in which R1 corresponds to line A-34 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A34.B1 to I.C.A34.B21).


Table 35c


Compounds of the formula I.C in which R1 corresponds to line A-35 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A35.B1 to I.C.A35.B21).


Table 36c


Compounds of the formula I.C in which R1 corresponds to line A-36 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A36.B1 to I.C.A36.B21).


Table 37c


Compounds of the formula I.C in which R1 corresponds to line A-37 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A37.B1 to I.C.A37.B21).


Table 38c


Compounds of the formula I.C in which R1 corresponds to line A-38 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A38.B1 to I.C.A38.B21).


Table 39c


Compounds of the formula I.C in which R1 corresponds to line A-39 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A39.B1 to I.C.A39.B21).


Table 40c


Compounds of the formula I.C in which R1 corresponds to line A-40 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A40.B1 to I.C.A40.B21).


Table 41c


Compounds of the formula I.C in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A41.B1 to I.C.A41.B21).


Table 42c


Compounds of the formula I.C in which R1 corresponds to line A-42 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A42.B1 to I.C.A42.B21).


Table 43c


Compounds of the formula I.C in which R1 corresponds to line A-43 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A43.B1 to I.C.A43.B21).


Table 44c


Compounds of the formula I.C in which R1 corresponds to line A-44 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A44.B1 to I.C.A44.B21).


Table 45c


Compounds of the formula I.C in which R1 corresponds to line A-45 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A45.B1 to I.C.A45.B21).


Table 46c


Compounds of the formula I.C in which R1 corresponds to line A-46 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A46.B1 to I.C.A46.B21).


Table 47c


Compounds of the formula I.C in which R1 corresponds to line A-47 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A47.B1 to I.C.A47.B21).


Table 48c


Compounds of the formula I.C in which R1 corresponds to line A-48 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A48.B1 to I.C.A48.B21).


Table 49c


Compounds of the formula I.C in which R1 corresponds to line A-49 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A49.B1 to I.C.A49.B21).


Table 50c


Compounds of the formula I.C in which R1 corresponds to line A-50 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A50.B1 to I.C.A50.B21).


Table 51c


Compounds of the formula I.C in which R1 corresponds to line A-51 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A51.B1 to I.C.A51.B21).


Table 52c


Compounds of the formula I.C in which R1 corresponds to line A-52 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A52.B1 to I.C.A52.B21).


Table 53c


Compounds of the formula I.C in which R1 corresponds to line A-53 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A53.B1 to I.C.A53.B21).


Table 54c


Compounds of the formula I.C in which R1 corresponds to line A-54 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A54.B1 to I.C.A54.B21).


Table 55c


Compounds of the formula I.C in which R1 corresponds to line A-55 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A55.B1 to I.C.A55.B21).


Table 56c


Compounds of the formula I.C in which R1 corresponds to line A-56 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A56.B1 to I.C.A56.B21).


Table 57c


Compounds of the formula I.C in which R1 corresponds to line A-57 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A57.B1 to I.C.A57.B21).


Table 58c


Compounds of the formula I.C in which R1 corresponds to line A-58 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A58.B1 to I.C.A58.B21).


Table 59c


Compounds of the formula I.C in which R1 corresponds to line A-59 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A59.B1 to I.C.A59.B21).


Table 60c


Compounds of the formula I.C in which R1 corresponds to line A-60 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A60.B1 to I.C.A60.B21).


Table 61c


Compounds of the formula I.C in which R1 corresponds to line A-61 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A61.B1 to I.C.A61.B21).


Table 62c


Compounds of the formula I.C in which R1 corresponds to line A-62 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A62.B1 to I.C.A62.B21).


Table 63c


Compounds of the formula I.C in which R1 corresponds to line A-63 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A63.B1 to I.C.A63.B21).


Table 64c


Compounds of the formula I.C in which R1 corresponds to line A-64 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A64.B1 to I.C.A64.B21).


Table 65c


Compounds of the formula I.C in which R1 corresponds to line A-65 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A65.B1 to I.C.A65.B21).


Table 66c


Compounds of the formula I.C in which R1 corresponds to line A-66 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A66.B1 to I.C.A66.B21).


Table 67c


Compounds of the formula I.C in which R1 corresponds to line A-67 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A67.B1 to I.C.A67.B21).


Table 68c


Compounds of the formula I.C in which R1 corresponds to line A-68 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A68.B1 to I.C.A68.B21).


Table 69c


Compounds of the formula I.C in which R1 corresponds to line A-69 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A69.B1 to I.C.A69.B21).


Table 70c


Compounds of the formula I.C in which R1 corresponds to line A-70 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A70.B1 to I.C.A70.B21).


Table 71c


Compounds of the formula I.C in which R1 corresponds to line A-71 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A71.B1 to I.C.A71.B21).


Table 72c


Compounds of the formula I.C in which R1 corresponds to line A-72 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A72.B1 to I.C.A72.B21).


Table 73c


Compounds of the formula I.C in which R1 corresponds to line A-73 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A73.B1 to I.C.A73.B21).


Table 74c


Compounds of the formula I.C in which R1 corresponds to line A-74 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A74.B1 to I.C.A74B21).


Table 75c


Compounds of the formula I.C in which R1 corresponds to line A-75 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A75.B1 to I.C.A75.B21).


Table 76c


Compounds of the formula I.C in which R1 corresponds to line A-76 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A76.B1 to I.C.A76.B21).


Table 77c


Compounds of the formula I.C in which R1 corresponds to line A-77 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A77.B1 to I.C.A77.B21).


Table 78c


Compounds of the formula I.C in which R1 corresponds to line A-78 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A78.B1 to I.C.A78.B21).


Table 79c


Compounds of the formula I.C in which R1 corresponds to line A-79 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A79.B1 to I.C.A79.B21).


Table 80c


Compounds of the formula I.C in which R1 corresponds to line A-80 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A80.B1 to I.C.A80.B21).


Table 81c


Compounds of the formula I.C in which R1 corresponds to line A-81 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A81.B1 to I.C.A81.B21).


Table 82c


Compounds of the formula I.C in which R1 corresponds to line A-82 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A82.B1 to I.C.A82.B21).


Table 83c


Compounds of the formula I.C in which R1 corresponds to line A-83 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A83.B1 to I.C.A83.B21).


Table 84c


Compounds of the formula I.C in which R1 corresponds to line A-84 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A84.B1 to I.C.A84.B21).


Table 85c


Compounds of the formula I.C in which R1 corresponds to line A-85 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A85.B1 to I.C.A85.B21).


Table 86c


Compounds of the formula I.C in which R1 corresponds to line A-86 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A86.B1 to I.C.A86.B21).


Table 87c


Compounds of the formula I.C in which R1 corresponds to line A-87 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A87.B1 to I.C.A87.B21).


Table 88c


Compounds of the formula I.C in which R1 corresponds to line A-88 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A88.B1 to I.C.A88.B21).


Table 89c


Compounds of the formula I.C in which R1 corresponds to line A-89 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A89.B1 to I.C.A89.B21).


Table 90c


Compounds of the formula I.C in which R1 corresponds to line A-90 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A90.B1 to I.C.A90.B21).


Table 91c


Compounds of the formula I.C in which R1 corresponds to line A-91 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A91.B1 to I.C.A91.B21).


Table 92c


Compounds of the formula I.C in which R1 corresponds to line A-92 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A92.B1 to I.C.A92.B21).


Table 93c


Compounds of the formula I.C in which R1 corresponds to line A-93 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A93.B1 to I.C.A93.B21).


Table 94c


Compounds of the formula I.C in which R1 corresponds to line A-94 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A94.B1 to I.C.A94.B21).


Table 95c


Compounds of the formula I.C in which R1 corresponds to line A-95 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A95.B1 to I.C.A95.B21).


Table 96c


Compounds of the formula I.C in which R1 corresponds to line A-96 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A96.B1 to I.C.A96.B21).


Table 97c


Compounds of the formula I.C in which R1 corresponds to line A-97 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A97.B1 to I.C.A97.B21).


Table 98c


Compounds of the formula I.C in which R1 corresponds to line A-98 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A98.B1 to I.C.A98.B21).


Table 99c


Compounds of the formula I.C in which R1 corresponds to line A-99 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A99.B1 to I.C.A99.B21).


Table 100c


Compounds of the formula I.C in which R1 corresponds to line A-100 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A100.B1 to I.C.A100.B21).


Table 101c


Compounds of the formula I.C in which R1 corresponds to line A-101 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.C.A101.B1 to I.C.A101.B21).


Table 102c


Table 1d


Compounds of the formula I.D in which R1 corresponds to line A-1 of Table A and the meaning R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A1.B1 to I.D.A1.B21).


Table 2d


Compounds of the formula I.D in which R1 corresponds to line A-2 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A2.B1 to I.D.A2.B21).


Table 3d


Compounds of the formula I.D in which R1 corresponds to line A-3 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A3.B1 to I.D.A3.B21).


Table 4d


Compounds of the formula I.D in which R1 corresponds to line A-4 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A4.B1 to I.D.A4.B21).


Table 5d


Compounds of the formula I.D in which R1 corresponds to line A-5 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A5.B1 to I.D.A5.B21).


Table 6d


Compounds of the formula I.D in which R1 corresponds to line A-6 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A6.B1 to I.D.A6.B21).


Table 7d


Compounds of the formula I.D in which R1 corresponds to line A-7 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A7.B1 to I.D.A7.B21).


Table 8d


Compounds of the formula I.D in which R1 corresponds to line A-8 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A8.B1 to I.D.A8.B21).


Table 9d


Compounds of the formula I.D in which R1 corresponds to line A-9 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A9.B1 to I.D.A9.B21).


Table 10d


Compounds of the formula I.D in which R1 corresponds to line A-10 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A10.B1 to I.D.A10.B21).


Table 11d


Compounds of the formula I.D in which R1 corresponds to line A-11 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A11.B1 to I.D.A11.B21).


Table 12d


Compounds of the formula I.D in which R1 corresponds to line A-12 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A12.B1 to I.D.A12.B21).


Table 13d


Compounds of the formula I.D in which R1 corresponds to line A-13 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A13.B1 to I.D.A13.B21).


Table 14d


Compounds of the formula I.D in which R1 corresponds to line A-14 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A14.B1 to I.D.A14.B21).


Table 15d


Compounds of the formula I.D in which R1 corresponds to line A-15 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A15.B1 to I.D.A15.B21).


Table 16d


Compounds of the formula I.D in which R1 corresponds to line A-16 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A16.B1 to I.D.A16.B21).


Table 17d


Compounds of the formula I.D in which R1 corresponds to line A-17 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A17.B1 to I.D.A17.B21).


Table 18d


Compounds of the formula I.D in which R1 corresponds to line A-18 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A18.B1 to I.D.A18.B21).


Table 19d


Compounds of the formula I.D in which R1 corresponds to line A-19 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A19.B1 to I.D.A19.B21).


Table 20d


Compounds of the formula I.D in which R1 corresponds to line A-20 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A20.B1 to I.D.A20.B21).


Table 21d


Compounds of the formula I.D in which R1 corresponds to line A-21 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A21.B1 to I.D.A21.B21).


Table 22d


Compounds of the formula I.D in which R1 corresponds to line A-22 of Table A and the meaning for the combination of (R4)m and R32 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A22.B1 to I.D.A22.B21).


Table 23d


Compounds of the formula I.D in which R1 corresponds to line A-23 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A23.B1 to I.D.A23.B21).


Table 24d


Compounds of the formula I.D in which R1 corresponds to line A-24 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A24.B1 to I.D.A24.B21).


Table 25d


Compounds of the formula I.D in which R1 corresponds to line A-25 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A25.B1 to I.D.A25.B21).


Table 26d


Compounds of the formula I.D in which R1 corresponds to line A-26 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A26.B1 to I.D.A26.B21).


Table 27d


Compounds of the formula I.D in which R1 corresponds to line A-27 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A27.B1 to I.D.A27.B21).


Table 28d


Compounds of the formula I.D in which R1 corresponds to line A-28 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A28.B1 to I.D.A28.B21).


Table 29d


Compounds of the formula I.D in which R1 corresponds to line A-29 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A29.B1 to I.D.A29.B21).


Table 30d


Compounds of the formula I.D in which R1 corresponds to line A-30 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A30.B1 to I.D.A30.B21).


Table 31d


Compounds of the formula I.D in which R1 corresponds to line A-31 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A31.B1 to I.D.A31.B21).


Table 32d


Compounds of the formula I.D in which R1 corresponds to line A-32 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A32.B1 to I.D.A32.B21).


Table 33d


Compounds of the formula I.D in which R1 corresponds to line A-33 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A33.B1 to I.D.A33.B21).


Table 34d


Compounds of the formula I.D in which R1 corresponds to line A-34 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A34.B1 to I.D.A34.B21).


Table 35d


Compounds of the formula I.D in which R1 corresponds to line A-35 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A35.B1 to I.D.A35.B21).


Table 36d


Compounds of the formula I.D in which R1 corresponds to line A-36 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A36.B1 to I.D.A36.B21).


Table 37d


Compounds of the formula I.D in which R1 corresponds to line A-37 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A37.B1 to I.D.A37.B21).


Table 38d


Compounds of the formula I.D in which R1 corresponds to line A-38 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A38.B1 to I.D.A38.B21).


Table 39d


Compounds of the formula I.D in which R1 corresponds to line A-39 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A39.B1 to I.D.A39.B21).


Table 40d


Compounds of the formula I.D in which R1 corresponds to line A-40 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A40.B1 to I.D.A40.B21).


Table 41d


Compounds of the formula I.D in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A41.B1 to I.D.A41.B21).


Table 42d


Compounds of the formula I.D in which R1 corresponds to line A-42 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A42.B1 to I.D.A42.B21).


Table 43d


Compounds of the formula I.D in which R1 corresponds to line A-43 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A43.B1 to I.D.A43.B21).


Table 44d


Compounds of the formula I.D in which R1 corresponds to line A-44 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A44.B1 to I.D.A44.B21).


Table 45d


Compounds of the formula I.D in which R1 corresponds to line A-45 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A45.B1 to I.D.A45.B21).


Table 46d


Compounds of the formula I.D in which R1 corresponds to line A-46 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A46.B1 to I.D.A46.B21).


Table 47d


Compounds of the formula I.D in which R1 corresponds to line A-47 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A47.B1 to I.D.A47.B21).


Table 48d


Compounds of the formula I.D in which R1 corresponds to line A-48 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A48.B1 to I.D.A48.B21).


Table 49d


Compounds of the formula I.D in which R1 corresponds to line A-49 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A49.B1 to I.D.A49.B21).


Table 50d


Compounds of the formula I.D in which R1 corresponds to line A-50 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A50.B1 to I.D.A50.B21).


Table 51d


Compounds of the formula I.D in which R1 corresponds to line A-51 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A51.B1 to I.D.A51.B21).


Table 52d


Compounds of the formula I.D in which R1 corresponds to line A-52 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A52.B1 to I.D.A52.B21).


Table 53d


Compounds of the formula I.D in which R1 corresponds to line A-53 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A53.B1 to I.D.A53.B21).


Table 54d


Compounds of the formula I.D in which R1 corresponds to line A-54 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A54.B1 to I.D.A54.B21).


Table 55d


Compounds of the formula I.D in which R1 corresponds to line A-55 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A55.B1 to I.D.A55.B21).


Table 56d


Compounds of the formula I.D in which R1 corresponds to line A-56 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A56.B1 to I.D.A56.B21).


Table 57d


Compounds of the formula I.D in which R1 corresponds to line A-57 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A57.B1 to I.D.A57.B21).


Table 58d


Compounds of the formula I.D in which R1 corresponds to line A-58 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A58.B1 to I.D.A58.B21).


Table 59d


Compounds of the formula I.D in which R1 corresponds to line A-59 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A59.B1 to I.D.A59.B21).


Table 60d


Compounds of the formula I.D in which R1 corresponds to line A-60 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A60.B1 to I.D.A60.B21).


Table 61d


Compounds of the formula I.D in which R1 corresponds to line A-61 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A61.B1 to I.D.A61.B21).


Table 62d


Compounds of the formula I.D in which R1 corresponds to line A-62 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A62.B1 to I.D.A62.B21).


Table 63d


Compounds of the formula I.D in which R1 corresponds to line A-63 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A63.B1 to I.D.A63.B21).


Table 64d


Compounds of the formula I.D in which R1 corresponds to line A-64 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A64.B1 to I.D.A64.B21).


Table 65d


Compounds of the formula I.D in which R1 corresponds to line A-65 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A65.B1 to I.D.A65.B21).


Table 66d


Compounds of the formula I.D in which R1 corresponds to line A-66 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A66.B1 to I.D.A66.B21).


Table 67d


Compounds of the formula I.D in which R1 corresponds to line A-67 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A67.B1 to I.D.A67.B21).


Table 68d


Compounds of the formula I.D in which R1 corresponds to line A-68 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A68.B1 to I.D.A68.B21).


Table 69d


Compounds of the formula I.D in which R1 corresponds to line A-69 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A69.B1 to I.D.A69.B21).


Table 70d


Compounds of the formula I.D in which R1 corresponds to line A-70 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A70.B1 to I.D.A70.B21).


Table 71d


Compounds of the formula I.D in which R1 corresponds to line A-71 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A71.B1 to I.D.A71.B21).


Table 72d


Compounds of the formula I.D in which R1 corresponds to line A-72 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A72.B1 to I.D.A72.B21).


Table 73d


Compounds of the formula I.D in which R1 corresponds to line A-73 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A73.B1 to I.D.A73.B21).


Table 74d


Compounds of the formula I.D in which R1 corresponds to line A-74 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A74.B1 to I.D.A74B21).


Table 75d


Compounds of the formula I.D in which R1 corresponds to line A-75 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A75.B1 to I.D.A75.B21).


Table 76d


Compounds of the formula I.D in which R1 corresponds to line A-76 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A76.B1 to I.D.A76.B21).


Table 77d


Compounds of the formula I.D in which R1 corresponds to line A-77 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A77.B1 to I.D.A77.B21).


Table 78d


Compounds of the formula I.D in which R1 corresponds to line A-78 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A78.B1 to I.D.A78.B21).


Table 79d


Compounds of the formula I.D in which R1 corresponds to line A-79 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A79.B1 to I.D.A79.B21).


Table 80d


Compounds of the formula I.D in which R1 corresponds to line A-80 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A80.B1 to I.D.A80.B21).


Table 81d


Compounds of the formula I.D in which R1 corresponds to line A-81 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A81.B1 to I.D.A81.B21).


Table 82d


Compounds of the formula I.D in which R1 corresponds to line A-82 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A82.B1 to I.D.A82.B21).


Table 83d


Compounds of the formula I.D in which R1 corresponds to line A-83 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A83.B1 to I.D.A83.B21).


Table 84d


Compounds of the formula I.D in which R1 corresponds to line A-84 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A84.B1 to I.D.A84.B21).


Table 85d


Compounds of the formula I.D in which R1 corresponds to line A-85 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A85.B1 to I.D.A85.B21).


Table 86d


Compounds of the formula I.D in which R1 corresponds to line A-86 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A86.B1 to I.D.A86.B21).


Table 87d


Compounds of the formula I.D in which R1 corresponds to line A-87 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A87.B1 to I.D.A87.B21).


Table 88d


Compounds of the formula I.D in which R1 corresponds to line A-88 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A88.B1 to I.D.A88.B21).


Table 89d


Compounds of the formula I.D in which R1 corresponds to line A-89 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A89.B1 to I.D.A89.B21).


Table 90d


Compounds of the formula I.D in which R1 corresponds to line A-90 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A90.B1 to I.D.A90.B21).


Table 91d


Compounds of the formula I.D in which R1 corresponds to line A-91 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A91.B1 to I.D.A91.B21).


Table 92d


Compounds of the formula I.D in which R1 corresponds to line A-92 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A92.B1 to I.D.A92.B21).


Table 93d


Compounds of the formula I.D in which R1 corresponds to line A-93 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A93.B1 to I.D.A93.B21).


Table 94d


Compounds of the formula I.D in which R1 corresponds to line A-94 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A94.B1 to I.D.A94.B21).


Table 95d


Compounds of the formula I.D in which R1 corresponds to line A-95 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A95.B1 to I.D.A95.B21).


Table 96d


Compounds of the formula I.D in which R1 corresponds to line A-96 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A96.B1 to I.D.A96.B21).


Table 97d


Compounds of the formula I.D in which R1 corresponds to line A-97 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A97.B1 to I.D.A97.B21).


Table 98d


Compounds of the formula I.D in which R1 corresponds to line A-98 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A98.B1 to I.D.A98.B21).


Table 99d


Compounds of the formula I.D in which R1 corresponds to line A-99 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A99.B1 to I.D.A99.B21).


Table 100d


Compounds of the formula I.D in which R1 corresponds to line A-100 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A100.B1 to I.D.A100.B21).


Table 101d


Compounds of the formula I.D in which R1 corresponds to line A-101 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.D.A101.B1 to I.D.A101.B21).


Table 102d


Table 1e


Compounds of the formula I.E in which R1 corresponds to line A-1 of Table A and the meaning R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A1.B1 to I.E.A1.B21).


Table 2e


Compounds of the formula I.E in which R1 corresponds to line A-2 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A2.B1 to I.E.A2.B21).


Table 3e


Compounds of the formula I.E in which R1 corresponds to line A-3 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A3.B1 to I.E.A3.B21).


Table 4e


Compounds of the formula I.E in which R1 corresponds to line A-4 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A4.B1 to I.E.A4.B21).


Table 5e


Compounds of the formula I.E in which R1 corresponds to line A-5 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A5.B1 to I.E.A5.B21).


Table 6e


Compounds of the formula I.E in which R1 corresponds to line A-6 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A6.B1 to I.E.A6.B21).


Table 7e


Compounds of the formula I.E in which R1 corresponds to line A-7 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A7.B1 to I.E.A7.B21).


Table 8e


Compounds of the formula I.E in which R1 corresponds to line A-8 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A8.B1 to I.E.A8.B21).


Table 9e


Compounds of the formula I.E in which R1 corresponds to line A-9 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A9.B1 to I.E.A9.B21).


Table 10e


Compounds of the formula I.E in which R1 corresponds to line A-10 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A10.B1 to I.E.A10.B21).


Table 11e


Compounds of the formula I.E in which R1 corresponds to line A-11 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A11.B1 to I.E.A11.B21).


Table 12e


Compounds of the formula I.E in which R1 corresponds to line A-12 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A12.B1 to I.E.A12.B21).


Table 13e


Compounds of the formula I.E in which R1 corresponds to line A-13 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A13.B1 to I.E.A13.B21).


Table 14e


Compounds of the formula I.E in which R1 corresponds to line A-14 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A14.B1 to I.E.A14.B21).


Table 15e


Compounds of the formula I.E in which R1 corresponds to line A-15 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A15.B1 to I.E.A15.B21).


Table 16e


Compounds of the formula I.E in which R1 corresponds to line A-16 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A16.B1 to I.E.A16.B21).


Table 17e


Compounds of the formula I.E in which R1 corresponds to line A-17 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A17.B1 to I.E.A17.B21).


Table 18e


Compounds of the formula I.E in which R1 corresponds to line A-18 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A18.B1 to I.E.A18.B21).


Table 19e


Compounds of the formula I.E in which R1 corresponds to line A-19 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A19.B1 to I.E.A19.B21).


Table 20e


Compounds of the formula I.E in which R1 corresponds to line A-20 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A20.B1 to I.E.A20.B21).


Table 21e


Compounds of the formula I.E in which R1 corresponds to line A-21 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A21.B1 to I.E.A21.B21).


Table 22e


Compounds of the formula I.E in which R1 corresponds to line A-22 of Table A and the meaning for the combination of (R4)m and R32 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A22.B1 to I.E.A22.B21).


Table 23e


Compounds of the formula I.E in which R1 corresponds to line A-23 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A23.B1 to I.E.A23.B21).


Table 24e


Compounds of the formula I.E in which R1 corresponds to line A-24 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A24.B1 to I.E.A24.B21).


Table 25e


Compounds of the formula I.E in which R1 corresponds to line A-25 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A25.B1 to I.E.A25.B21).


Table 26e


Compounds of the formula I.E in which R1 corresponds to line A-26 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A26.B1 to I.E.A26.B21).


Table 27e


Compounds of the formula I.E in which R1 corresponds to line A-27 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A27.B1 to I.E.A27.B21).


Table 28e


Compounds of the formula I.E in which R1 corresponds to line A-28 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A28.B1 to I.E.A28.B21).


Table 29e


Compounds of the formula I.E in which R1 corresponds to line A-29 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A29.B1 to I.E.A29.B21).


Table 30e


Compounds of the formula I.E in which R1 corresponds to line A-30 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A30.B1 to I.E.A30.B21).


Table 31e


Compounds of the formula I.E in which R1 corresponds to line A-31 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A31.B1 to I.E.A31.B21).


Table 32e


Compounds of the formula I.E in which R1 corresponds to line A-32 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A32.B1 to I.E.A32.B21).


Table 33e


Compounds of the formula I.E in which R1 corresponds to line A-33 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A33.B1 to I.E.A33.B21).


Table 34e


Compounds of the formula I.E in which R1 corresponds to line A-34 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A34.B1 to I.E.A34.B21).


Table 35e


Compounds of the formula I.E in which R1 corresponds to line A-35 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A35.B1 to I.E.A35.B21).


Table 36e


Compounds of the formula I.E in which R1 corresponds to line A-36 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A36.B1 to I.E.A36.B21).


Table 37e


Compounds of the formula I.E in which R1 corresponds to line A-37 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A37.B1 to I.E.A37.B21).


Table 38e


Compounds of the formula I.E in which R1 corresponds to line A-38 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A38.B1 to I.E.A38.B21).


Table 39e


Compounds of the formula I.E in which R1 corresponds to line A-39 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A39.B1 to I.E.A39.B21).


Table 40e


Compounds of the formula I.E in which R1 corresponds to line A-40 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A40.B1 to I.E.A40.B21).


Table 41e


Compounds of the formula I.E in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A41.B1 to I.E.A41.B21).


Table 42e


Compounds of the formula I.E in which R1 corresponds to line A-41 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A42.B1 to I.E.A42.B21).


Table 43e


Compounds of the formula I.E in which R1 corresponds to line A-43 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A43.B1 to I.E.A43.B21).


Table 44e


Compounds of the formula I.E in which R1 corresponds to line A-44 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A44.B1 to I.E.A44.B21).


Table 45e


Compounds of the formula I.E in which R1 corresponds to line A-45 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A45.B1 to I.E.A45.B21).


Table 46e


Compounds of the formula I.E in which R1 corresponds to line A-46 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A46.B1 to I.E.A46.B21).


Table 47e


Compounds of the formula I.E in which R1 corresponds to line A-47 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A47.B1 to I.E.A47.B21).


Table 48e


Compounds of the formula I.E in which R1 corresponds to line A-48 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A48.B1 to I.E.A48.B21).


Table 49e


Compounds of the formula I.E in which R1 corresponds to line A-49 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A49.B1 to I.E.A49.B21).


Table 50e


Compounds of the formula I.E in which R1 corresponds to line A-50 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A50.B1 to I.E.A50.B21).


Table 51e


Compounds of the formula I.E in which R1 corresponds to line A-51 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A51.B1 to I.E.A51.B21).


Table 52e


Compounds of the formula I.E in which R1 corresponds to line A-52 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A52.B1 to I.E.A52.B21).


Table 53e


Compounds of the formula I.E in which R1 corresponds to line A-53 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A53.B1 to I.E.A53.B21).


Table 54e


Compounds of the formula I.E in which R1 corresponds to line A-54 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A54.B1 to I.E.A54.B21).


Table 55e


Compounds of the formula I.E in which R1 corresponds to line A-55 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A55.B1 to I.E.A55.B21).


Table 56e


Compounds of the formula I.E in which R1 corresponds to line A-56 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A56.B1 to I.E.A56.B21).


Table 57e


Compounds of the formula I.E in which R1 corresponds to line A-57 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A57.B1 to I.E.A57.B21).


Table 58e


Compounds of the formula I.E in which R1 corresponds to line A-58 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A58.B1 to I.E.A58.B21).


Table 59e


Compounds of the formula I.E in which R1 corresponds to line A-59 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A59.B1 to I.E.A59.B21).


Table 60e


Compounds of the formula I.E in which R1 corresponds to line A-60 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A60.B1 to I.E.A60.B21).


Table 61e


Compounds of the formula I.E in which R1 corresponds to line A-61 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A61.B1 to I.E.A61.B21).


Table 62e


Compounds of the formula I.E in which R1 corresponds to line A-62 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A62.B1 to I.E.A62.B21).


Table 63e


Compounds of the formula I.E in which R1 corresponds to line A-63 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A63.B1 to I.E.A63.B21).


Table 64e


Compounds of the formula I.E in which R1 corresponds to line A-64 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A64.B1 to I.E.A64.B21).


Table 65e


Compounds of the formula I.E in which R1 corresponds to line A-65 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A65.B1 to I.E.A65.B21).


Table 66e


Compounds of the formula I.E in which R1 corresponds to line A-66 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A66.B1 to I.E.A66.B21).


Table 67e


Compounds of the formula I.E in which R1 corresponds to line A-67 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A67.B1 to I.E.A67.B21).


Table 68e


Compounds of the formula I.E in which R1 corresponds to line A-68 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A68.B1 to I.E.A68.B21).


Table 69e


Compounds of the formula I.E in which R1 corresponds to line A-69 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A69.B1 to I.E.A69.B21).


Table 70e


Compounds of the formula I.E in which R1 corresponds to line A-70 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A70.B1 to I.E.A70.B21).


Table 71e


Compounds of the formula I.E in which R1 corresponds to line A-71 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A71.B1 to I.E.A71.B21).


Table 72e


Compounds of the formula I.E in which R1 corresponds to line A-72 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A72.B1 to I.E.A72.B21).


Table 73e


Compounds of the formula I.E in which R1 corresponds to line A-73 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A73.B1 to I.E.A73.B21).


Table 74e


Compounds of the formula I.E in which R1 corresponds to line A-74 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A74.B1 to I.E.A74B21).


Table 75e


Compounds of the formula I.E in which R1 corresponds to line A-75 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A75.B1 to I.E.A75.B21).


Table 76e


Compounds of the formula I.E in which R1 corresponds to line A-76 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A76.B1 to I.E.A76.B21).


Table 77e


Compounds of the formula I.E in which R1 corresponds to line A-77 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A77.B1 to I.E.A77.B21).


Table 78e


Compounds of the formula I.E in which R1 corresponds to line A-78 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A78.B1 to I.E.A78.B21).


Table 79e


Compounds of the formula I.E in which R1 corresponds to line A-79 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A79.B1 to I.E.A79.B21).


Table 80e


Compounds of the formula I.E in which R1 corresponds to line A-80 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A80.B1 to I.E.A80.B21).


Table 81e


Compounds of the formula I.E in which R1 corresponds to line A-81 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A81.B1 to I.E.A81.B21).


Table 82e


Compounds of the formula I.E in which R1 corresponds to line A-82 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A82.B1 to I.E.A82.B21).


Table 83e


Compounds of the formula I.E in which R1 corresponds to line A-83 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A83.B1 to I.E.A83.B21).


Table 84e


Compounds of the formula I.E in which R1 corresponds to line A-84 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A84.B1 to I.E.A84.B21).


Table 85e


Compounds of the formula I.E in which R1 corresponds to line A-85 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A85.B1 to I.E.A85.B21).


Table 86e


Compounds of the formula I.E in which R1 corresponds to line A-86 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A86.B1 to I.E.A86.B21).


Table 87e


Compounds of the formula I.E in which R1 corresponds to line A-87 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A87.B1 to I.E.A87.B21).


Table 88e


Compounds of the formula I.E in which R1 corresponds to line A-88 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A88.B1 to I.E.A88.B21).


Table 89e


Compounds of the formula I.E in which R1 corresponds to line A-89 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A89.B1 to I.E.A89.B21).


Table 90e


Compounds of the formula I.E in which R1 corresponds to line A-90 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A90.B1 to I.E.A90.B21).


Table 91e


Compounds of the formula I.E in which R1 corresponds to line A-91 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A91.B1 to I.E.A91.B21).


Table 92e


Compounds of the formula I.E in which R1 corresponds to line A-92 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A92.B1 to I.E.A92.B21).


Table 93e


Compounds of the formula I.E in which R1 corresponds to line A-93 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A93.B1 to I.E.A93.B21).


Table 94e


Compounds of the formula I.E in which R1 corresponds to line A-94 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A94.B1 to I.E.A94.B21).


Table 95e


Compounds of the formula I.E in which R1 corresponds to line A-95 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A95.B1 to I.E.A95.B21).


Table 96e


Compounds of the formula I.E in which R1 corresponds to line A-96 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A96.B1 to I.E.A96.B21).


Table 97e


Compounds of the formula I.E in which R1 corresponds to line A-97 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A97.B1 to I.E.A97.B21).


Table 98e


Compounds of the formula I.E in which R1 corresponds to line A-98 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A98.B1 to I.E.A98.B21).


Table 99e


Compounds of the formula I.E in which R1 corresponds to line A-99 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A99.B1 to I.E.A99.B21).


Table 100e


Compounds of the formula I.E in which R1 corresponds to line A-100 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A100.B1 to I.E.A100.B21).


Table 101e


Compounds of the formula I.E in which R1 corresponds to line A-101 of Table A and the meaning for R2 for each individual compound corresponds in each case to one line of Table B (compounds I.E.A101.B1 to I.E.A101.B21).












TABLE A








R1









A-1
H



A-2
—CH3



A-3
—CH2CH3



A-4
—CH2CH2CH3



A-5
—CH(CH3)2



A-6
—CH2CH2CH2CH3



A-7
—CH(CH2CH3)2



A-8
—C(CH3)3



A-9
—CH2CH(CH3)2



A-10
—CH2CH2CH2CH2CH3



A-11
—CH2CH2CH2CH2CH2CH3



A-12
CF3



A-13
CHF2



A-14
—CH═CH2



A-15
—CH═CHCH3



A-16
—CH2CH═CH2



A-17
—C≡CH



A-18
—C≡CCH3



A-19
—CH2C≡CH



A-20
—C3H5 (cyclopropyl)



A-21
—C5H9 (cyclopentyl)



A-22
phenyl



A-23
benzyl



A-24
4-Cl-phenyl



A-25
2,4-Cl2-phenyl



A-26
OH



A-27
OCH3



A-28
OCH2CH3



A-29
OCH2CH2CH3



A-30
OCH(CH3)2



A-31
OCH2CH2CH2CH3



A-32
OCH(CH2CH3)2



A-33
OC(CH3)3



A-34
OCH2CH(CH3)2



A-35
OCH2CH2CH2CH2CH3



A-36
OCH2CH2CH2CH2CH2CH3



A-37
NMe2



A-38
NEt2



A-39
CH2CF3



A-40
CH(CH3)CH2CH3



A-41
CH2CH2CH═CH2



A-42
CH(CH3)CH(OCH3)2



A-43
NH2



A-44
NHMe



A-45
NHEt



A-46
CH2OH



A-47
CH2Cl



A-48
CH2Br



A-49
CH2OMe



A-50
CH2OEt



A-51
CH2OCH2CH2CH3



A-52
CH2OCH(CH3)2



A-53
CH2OCH2CH2CH2CH3



A-54
CH2



A-55
CH2CN



A-56
CH2CH2CN



A-57
CH2OCHF2



A-58
CH2OCF3



A-59
CH2COOH



A-60
CH2COOMe



A-61
CH2COOEt



A-62
CH2CONH2



A-63
CH2CONHMe



A-64
CH2CONHEt



A-65
CH2CON(Me)2



A-66
CH2CON(Et)2



A-67
CH(CH3)CN



A-68
CH(CH3)CH2CN



A-69
CH(CH3)OCHF2



A-70
CH(CH3)OCF3



A-71
CH(CH3)COOH



A-72
CH(CH3)COOMe



A-73
CH(CH3)COOEt



A-74
CH(CH3)CONH2



A-75
CH(CH3)CONHMe



A-76
CH(CH3)CONHEt



A-77
CH(CH3)CON(Me)2



A-78
CH(CH3)CON(Et)2



A-79
C(CH3)2CN



A-80
C(CH3)2CH2CN



A-81
C(CH3)2OCHF2



A-82
C(CH3)2OCF3



A-83
C(CH3)2COOH



A-84
C(CH3)2COOMe



A-85
C(CH3)2COOEt



A-86
C(CH3)2CONH2



A-87
C(CH3)2CONHMe



A-88
C(CH3)2CONHEt



A-89
C(CH3)2CON(Me)2



A-90
C(CH3)2CON(Et)2



A-91
CHO



A-92
COOH



A-93
COOMe



A-94
COOEt



A-95
CONH2



A-96
CONHMe



A-97
CONHEt



A-98
CON(Me)2



A-99
CON(Et)2



A-100
CN



A-101
cyclohexyl




















TABLE B








R2









B-1
CN



B-2
NO2



B-3
—C(═O)CH3



B-4
—C(═O)CH2CH3



B-5
—C(═O)CH(CH3)2



B-6
—C(═O)C(CH3)3



B-7
—C(═O)OH



B-8
—C(═O)OCH3



B-9
—C(═O)OCH2CH3



B-10
—C(═O)OCH(CH3)2



B-11
—C(═O)OC(CH3)3



B-12
—C(═O)NH2



B-13
—C(═O)NHCH3



B-14
—C(═O)NHCH2CH3



B-15
—C(═O)NHCH(CH3)2



B-16
—C(═O)NHC(CH3)3



B-17
—C(═O)N(CH3)2



B-18
—C(═O)N(CH2CH3)2



B-19
—C(═O)N(CH(CH3)2)2



B-20
—C(═O)N(C(CH3)3)2



B-21
H










The compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.


The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants.


Preferably, compounds I and compositions thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.


The term “plant propagation material” is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.


Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.


The term “cultivated plants” is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties.


Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxylphenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase (PDS) inhibitors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61, 2005, 246; 61, 2005, 258; 61, 2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1185; and references quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate-tolerant, Monsanto, U.S.A.), Cultivance® (imidazolinone tolerant, BASF SE, Germany) and LibertyLink® (glufosinate-tolerant, Bayer CropScience, Germany).


Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as 5-endotoxins, e. g. CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b), CryIIIA, CryIIIB(b1) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO 02/015701). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 and WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of athropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard® (corn cultivars producing the Cry1Ab toxin), YieldGard® Plus (corn cultivars producing Cry1Ab and Cry3Bb1 toxins), Starlink® (corn cultivars producing the Cry9c toxin), Herculex® RW (corn cultivars producing Cry34Ab1, Cry35Ab1 and the enzyme Phosphinothricin-N-Acetyltransferase [PAT]); NuCOTN® 33B (cotton cultivars producing the Cry1Ac toxin), Bollgard® I (cotton cultivars producing the Cry1Ac toxin), Bollgard® II (cotton cultivars producing Cry1Ac and Cry2Ab2 toxins); VIPCOT® (cotton cultivars producing a VIP-toxin); NewLeaf® (potato cultivars producing the Cry3A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Bt11 (e. g. Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the Cry1Ab toxin and PAT enzyme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the Cry1Ac toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1F toxin and PAT enzyme).


Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called “pathogenesis-related proteins” (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.


Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera® rape, DOW Agro Sciences, Canada).


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora® potato, BASF SE, Germany).


The compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases:



Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. candida) and sunflowers (e. g. A. tragopogonis); Alternaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici (anthracnose) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochllobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e.g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e.g. Gray leaf spot: C. zeae-maydis), rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochllobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C. gossypii), corn (e. g. C. graminicola: Anthracnose stalk rot), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. gloeosporiodes); Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees; Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C. liriodendri, teleomorph: Neonectria lirodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophllum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (E. pyri), soft fruits (E. veneta: anthracnose) and vines (E. ampelina: anthracnose); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets (E. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilium (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani (f. sp. glycines now syn. F. virguliforme) and F. tucumaniae and F. brasiliense each causing sudden death syndrome on soybeans and F. verticilliodes on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuroi: Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G. gossypii on cotton; Grainstaining complex on rice; Guignardia bidwellii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochliobolus) on corn, cereals and rice; Hemileia spp., e. g. H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P. tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans late blight) and broad-leaved trees (e. g. P. ramorum: sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Polymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpotrichoides (eyespot, teleomorph: Tapesia yallundae) on cereals, e. g. wheat or barley; Pseudoperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. humili on hop; Pseudopezicula tracheiphila (red fire disease or ‘rotbrenner’, anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagi on asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotima spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici(Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Odium tuckeri) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphacelotheca spp. (smut) on corn, (e. g. S. reiliana: head smut), sorghum and sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tilletia spp. (common bunt or stinking smut) on cereals, such as e. g. T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae on strawberries, rape, potatoes and tomatoes.


The compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term “protection of materials” is to be understood to denote the protection of technical and nonliving materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, coiling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichorma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae.


The compounds I and compositions thereof, respectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively.


The term “plant health” is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves (“greening effect”)), quality (e. g. improved content or composition of certain ingredients) and tolerance to abiotic and/or biotic stress. The above identified indicators for the health condition of a plant may be interdependent or may result from each other.


The compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention.


The compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.


Plant propagation materials may be treated with compounds I as such or a composition comprising at least one compound I prophylactically either at or before planting or transplanting.


The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I according to the invention.


An agrochemical composition comprises a fungicidally effective amount of a compound I. The term “effective amount” denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.


The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and compositions thereof. Examples for composition types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further compositions types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.


The compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.


Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.


Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and compositions thereof.


Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and compositions thereof.


Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and compositions thereof. Such surfactants can be used as emusifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).


Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and compositions thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.


Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and compositions thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.


Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.


Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target. Examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.


Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), anorganic clays (organically modified or unmodified), polycarboxylates, and silicates.


Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.


Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.


Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.


Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).


Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.


Examples for composition types and their preparation are:


i) Water-Soluble Concentrates (SL, LS)

10-60 wt % of a compound I and 5-15 wt % wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water.


ii) Dispersible Concentrates (DC)

5-25 wt % of a compound I and 1-10 wt % dispersant (e. g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion.


iii) Emulsifiable Concentrates (EC)


15-70 wt % of a compound I and 5-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion.


iv) Emulsions (EW, EO, ES)

5-40 wt % of a compound I and 1-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e.g. aromatic hydrocarbon). This composition is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.


v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt % of a compound I are comminuted with addition of 2-10 wt % dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0.1-2 wt % thickener (e.g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt % binder (e.g. polyvinylalcohol) is added.


vi) Water-Dispersible Granules and Water-Soluble Granules (WG, SG)

50-80 wt % of a compound I are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.


vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, WS)


50-80 wt % of a compound I are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e.g. sodium lignosulfonate), 1-3 wt % wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance.


viii) Gel (GW, GF)


In an agitated ball mill, 5-25 wt % of a compound I are comminuted with addition of 3-10 wt % dispersants (e.g. sodium lignosulfonate), 1-5 wt % thickener (e.g. carboxymethylcellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.


ix) Microemulsion (ME)

5-20 wt % of a compound I are added to 5-30 wt % organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 wt % surfactant blend (e.g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This composition is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.


x) Microcapsules (CS)

An oil phase comprising 5-50 wt % of a compound I, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound I according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4′-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS composition.


xi) Dustable powders (DP, DS)


1-10 wt % of a compound I are ground finely and mixed intimately with solid carrier (e.g. finely divided kaolin) ad 100 wt %.


xii) Granules (GR, FG)


0.5-30 wt % of a compound I is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or fluidized bed.


xiii) Ultra-Low Volume Liquids (UL)


1-50 wt % of a compound I are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %.


The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0.1-1 wt % anti-foaming agents, and 0.1-1 wt % colorants.


The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).


Solutions for seed treatment (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to-use preparations. Application can be carried out before or during sowing. Methods for applying compound I and compositions thereof, respectively, on to plant propagation material, especially seeds include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compound I or the compositions thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.


When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.


In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.


When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.


Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.


The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.


According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary composition may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.


Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.


The following list of active substances, in conjunction with which the compounds I can be used, is intended to illustrate the possible combinations but does not limit them:


A) Respiration inhibitors

    • Inhibitors of complex III at Qo site (e.g. strobilurins): azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;
    • inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate
      • inhibitors of complex II (e. g. carboxamides): benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide; N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide
      • N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide
    • other respiration inhibitors (e.g. complex I, uncouplers): diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin; and silthiofam;


B) Sterol biosynthesis inhibitors (SBI fungicides)

    • C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole,
    • 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole, 2-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol; 2-[2-chloro-4-(4-chlorophenoxyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol (B.1.33), 1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol (B.1.34), 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol (B.1.35), 2-[2-chloro-4-(4-chlorophenoxyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol (B.1.36), 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol (B.1.37), 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol (B.1.38), 2-[2-chloro-4-(4-chlorophenoxyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol (B.1.39), 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol (B.1.40), 2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine), [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;
    • Delta 14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;
    • Inhibitors of 3-keto reductase: fenhexamid;


C) Nucleic acid synthesis inhibitors

    • phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;
    • others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxyl)pyrimidin-4-amine;


D) Inhibitors of cell division and cytoskeleton

    • tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7-(4-methyl-piperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine
    • other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;


E) Inhibitors of amino acid and protein synthesis

    • methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim, pyrimethanil;
    • protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;


F) Signal transduction inhibitors

    • MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;
    • G protein inhibitors: quinoxyfen;


G) Lipid and membrane synthesis inhibitors

    • Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane;
    • lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
    • phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate and N-(1-(1-(4-cyano-phenyl)-ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
    • compounds affecting cell membrane permeability and fatty acids: propamocarb, —fatty acid amide hydrolase inhibitors: oxathiapiprolin, 2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl) 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate; H) Inhibitors with Multi Site Action
    • inorganic active substances: Bordeaux composition, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
    • thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, ziram;
    • organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;
    • guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone;


I) Cell wall synthesis inhibitors

    • inhibitors of glucan synthesis: validamycin, polyoxin B; melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;


J) Plant defence inducers

    • acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts;


K) Unknown mode of acti-bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, oxin-copper, proquinazid, tebufloquin, tecloftalam, tolprocarb, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl)cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide; and 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,


2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, ethyl(Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate (K.1.42), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline;


L) L) Biopesticides

    • L1) Microbial pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus amyloliquefaciens, B. mojavensis, B. pumilus, B. simplex, B. solisalsi, B. subtilis, B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f. catenulate (also named Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa, Pantoea vagans, Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, Trichoderma asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum; mixture of T. harzianum and T. viride; mixture of T. polysporum and T. harzianum; T. stromaticum, T. virens (also named Gliocladium virens), T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, zucchini yellow mosaic virus (avirulent strain);
    • L2) Biochemical pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: chitosan (hydrolysate), harpin protein, laminarin, Menhaden fish oil, natamycin, Plum pox virus coat protein, potassium or sodium bicarbonate, Reynoutria sachlinensis extract, salicylic acid, tea tree oil;
    • L3) Microbial pesticides with insecticidal, acaricidal, molluscidal and/or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia sp., Chromobacterium subtsugae, Cydia pomonella granulosis virus, Cryptophlebia leucotreta granulovirus (CrleGV), Isaria fumosorosea, Heterorhabditis bacteriophora, Lecanicillium longisporum, L. muscarium (formerly Verticillium lecanii), Metarhizium anisopliae, M. anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramose, P. reneformis, P. thornea, P. usgae, Pseudomonas fluorescens, Steinernema carpocapsae, S. feltiae, S. kraussei;
    • L4) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity: L-carvone, citral, (E,Z)-7,9-dodecadien-1-ylacetate, ethyl formate, (E,Z)-2,4-ethyl decadienoate (pear ester), (Z,Z,E)-7,11,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1-butanol, methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1-ol, (E,Z)-2,13-octadecadien-1-ol acetate, (E,Z)-3,13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone, potassium silicate, sorbitol actanoate, (E,Z,Z)-3,8,11-tetradecatrienyl acetate, (Z,E)-9,12-tetradecadien-1-ylacetate, Z-7-tetradecen-2-one, Z-9-tetradecen-1-ylacetate, Z-11-tetradecenal, Z-11-tetradecen-1-ol, Acacia negra extract, extract of grapefruit seeds and pulp, extract of Chenopodium ambrosiodae, Catnip oil, Neem oil, Quillay extract, Tagetes oil;
    • L5) Microbial pesticides with plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity: Azospirillum amazonense, A. brasilense, A. lipoferum, A. irakense, A. halopraeferens, Bradyrhizobium sp., B. elkanii, B. japonicum, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium sp., Paenibacillus alvei, Penicillium bilaiae, Rhizobium leguminosarum bv. phaseoli RG-B10 (L.5.54), R. l. bv. trifolii RP113-7 (L.5.55), R. l. bv. trifolii 095 (L.5.63), R. l. bv. trifolii TA1 (L.5.64), R. l. bv. trifolii CC283b (L.5.65), R. l. bv. trifolii CC275e (L.5.66), R. l. bv. trifolii CB782 (L.5.67), R. l. bv. trifolii CC1099 (L.5.68), R. l. bv. trifolii WSM1325 (L.5.69), R. l. bv. viciae SU303 (L.5.56), R. l. bv. viciae WSM1455 (L.5.57), R. l. bv. viciae P1NP3Cst (L.5.58) R. l. bv. viciae RG-P2 (L.5.70), R. tropici SEMIA 4080 (L.5.59), R. tropici SEMIA 4077 (L.5.71), R. tropici CC511 (L.5.72), Sinorhizobium meliloti MSDJ0848 (L.5.60), S. meliloti NRG185 (L.5.61), S. meliloti RR1128, (L.5.62); R. l. trifolii, R. l. bv. viciae, R. tropici, Sinorhizobium meliloti;
    • L6) Biochemical pesticides with plant stress reducing, plant growth regulator and/or plant yield enhancing activity: abscisic acid, aluminium silicate (kaolin), 3-decen-2-one, formononetin, genistein, hesperetin, homobrassinlide, humates, jasmonic acid or salts or derivatives thereof, lysophosphatidyl ethanolamine, naringenin, polymeric polyhydroxy acid, Ascophyllum nodosum (Norwegian kelp, Brown kelp) extract and Ecklonia maxima (kelp) extract;


M) Growth regulators


abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride), naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid, trinexapac-ethyl and uniconazole;


N) Herbicides

    • acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, flufenacet, mefenacet, metolachlor, metazachlor, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;
    • amino acid derivatives: bilanafos, glyphosate, glufosinate, sulfosate;
    • aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuryl;
    • Bipyridyls: diquat, paraquat;
    • (thio)carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;
    • cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;
    • dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin;
    • diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen;
    • hydroxybenzonitriles: bomoxynil, dichlobenil, ioxynil;
    • imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;
    • phenoxy acetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;
    • pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazon, pyridate;
    • pyridines: aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, picolinafen, thiazopyr;
    • sulfonyl ureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metazosulfuron, metsulfuron-methyl, nicosulfuron, oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;
    • triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazinone, metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;
    • ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, methabenzthiazuron, tebuthiuron;
    • other acetolactate synthase inhibitors: bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, pyroxsulam;
    • others: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl, chlorthal, cinmethylin, clomazone, cumyluron, cyprosulfamide, dicamba, difenzoquat, diflufenzopyr, Drechslera monoceras, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac, mesotrione, methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester.


O) Insecticides

    • organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phosphamidon, phorate, phoxim, pirimiphosmethyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;
    • carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;
    • pyrethroids: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alphacypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin;
    • insect growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyramazin, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;
    • nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran, flupyradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-2-chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinane;
    • GABA antagonist compounds: endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1-(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1H-pyrazole-3-carbothioic acid amide;
    • macrocyclic lactone insecticides: abamectin, emamectin, milbemectin, lepimectin, spinosad, spinetoram;
    • mitochondrial electron transport inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;
    • METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon;
    • Uncouplers: chlorfenapyr;
    • oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;
    • moulting disruptor compounds: cryomazine;
    • mixed function oxidase inhibitors: piperonyl butoxide;
    • sodium channel blockers: indoxacarb, metaflumizone;
    • ryanodine receptor inhibitors: chlorantraniliprole, cyantraniliprole, flubendiamide, N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;
      • others: benclothiaz, bifenazate, cartap, flonicamid, pyridalyl, pymetrozine, sulfur, thiocyclam, flubendiamide, chlorantraniliprole, cyazypyr (HGW86), cyenopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron, pyrifluquinazon and 1,1′-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]cyclopropaneacetic acid ester.


The present invention furthermore relates to agrochemical compositions comprising a composition of at least one compound I (component 1) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to O) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to L), as described above, and if desired one suitable solvent or solid carrier. Those compositions are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi. Furthermore, combating harmful fungi with a composition of compounds I and at least one fungicide from groups A) to L), as described above, is more efficient than combating those fungi with individual compounds I or individual fungicides from groups A) to L). By applying compounds I together with at least one active substance from groups A) to O) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is obtained (synergistic compositions).


This can be obtained by applying the compounds I and at least one further active substance simultaneously, either jointly (e. g. as tank-mix) or separately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance applied first still occurs at the site of action in a sufficient amount at the time of application of the further active substance(s). The order of application is not essential for working of the present invention.


In binary compositions, i.e. compositions according to the invention comprising one compound I (component 1) and one further active substance (component 2), e. g. one active substance from groups A) to O), the weight ratio of component 1 and component 2 generally depends from the properties of the active substances used, usually it is in the range of from 1:100 to 100:1, regularly in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, more preferably in the range of from 1:10 to 10:1 and in particular in the range of from 1:3 to 3:1.


In ternary compositions, i.e. compositions according to the invention comprising one compound I (component 1) and a first further active substance (component 2) and a second further active substance (component 3), e. g. two active substances from groups A) to O), the weight ratio of component 1 and component 2 depends from the properties of the active substances used, preferably it is in the range of from 1:50 to 50:1 and particularly in the range of from 1:10 to 10:1, and the weight ratio of component 1 and component 3 preferably is in the range of from 1:50 to 50:1 and particularly in the range of from 1:10 to 10:1.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group A) (component 2) and particularly selected from azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin; famoxadone, fenamidone; benzovindiflupyr, bixafen, boscalid, fluopyram, fluxapyroxad, isopyrazam, penflufen, penthiopyrad, sedaxane; ametoctradin, cyazofamid, fluazinam, fentin salts, such as fentin acetate.


Preference is given to compositions comprising a compound of formula I (component 1) and at least one active substance selected from group B) (component 2) and particularly selected from cyproconazole, difenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, fenarimol, triforine; dodemorph, fenpropimorph, tridemorph, fenpropidin, spiroxamine; fenhexamid.


Preference is given to compositions comprising a compound of formula I (component 1) and at least one active substance selected from group C) (component 2) and particularly selected from metalaxyl, (metalaxyl-M) mefenoxam, ofurace.


Preference is given to compositions comprising a compound of formula I (component 1) and at least one active substance selected from group D) (component 2) and particularly selected from benomyl, carbendazim, thiophanate-methyl, ethaboxam, fluopicolide, zoxamide, metrafenone, pyriofenone.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group E) (component 2) and particularly selected from cyprodinil, mepanipyrim, pyrimethanil.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group F) (component 2) and particularly selected from iprodione, fludioxonil, vinclozolin, quinoxyfen.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group G) (component 2) and particularly selected from dimethomorph, flumorph, iprovalicarb, benthiavalicarb, mandipropamid, propamocarb.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group H) (component 2) and particularly selected from copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, mancozeb, metiram, propineb, thiram, captafol, folpet, chlorothalonil, dichlofluanid, dithianon.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group I) (component 2) and particularly selected from carpropamid and fenoxanil.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group J) (component 2) and particularly selected from acibenzolar-S-methyl, probenazole, tiadinil, fosetyl, fosetyl-aluminium, H3PO3 and salts thereof.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group K) (component 2) and particularly selected from cymoxanil, proquinazid and N-methyl-2-{1-[(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-thiazolecarboxamide.


Preference is also given to compositions comprising a compound I (component 1) and at least one active substance selected from group L) (component 2) and particularly selected from Bacillus subtilis strain NRRL No. B-21661, Bacillus pumilus strain NRRL No. B-30087 and Ulocladium oudemansii.


Accordingly, the present invention furthermore relates to compositions comprising one compound I (component 1) and one further active substance (component 2), which further active substance is selected from the column “Component 2” of the lines B-1 to B-369 of Table C.


A further embodiment relates to the compositions B-1 to B-369 listed in Table C, where a row of Table B corresponds in each case to a fungicidal composition comprising one of the in the present specification individualized compounds of formula I (component 1) and the respective further active substance from groups A) to O) (component 2) stated in the row in question. Preferably, the compositions described comprise the active substances in synergistically effective amounts.









TABLE C







Composition comprising one indivivalized compound I and one


further active substance from groups A) to O)









Compo-




sition
Component 1
Component 2





C-1
one individualized compound I
Azoxystrobin


C-2
one individualized compound I
Coumethoxystrobin


C-3
one individualized compound I
Coumoxystrobin


C-4
one individualized compound I
Dimoxystrobin


C-5
one individualized compound I
Enestroburin


C-6
one individualized compound I
Fenaminstrobin


C-7
one individualized compound I
Fenoxystrobin/




Flufenoxystrobin


C-8
one individualized compound I
Fluoxastrobin


C-9
one individualized compound I
Kresoxim-methyl


C-10
one individualized compound I
Metominostrobin


C-11
one individualized compound I
Orysastrobin


C-12
one individualized compound I
Picoxystrobin


C-13
one individualized compound I
Pyraclostrobin


C-14
one individualized compound I
Pyrametostrobin


C-15
one individualized compound I
Pyraoxystrobin


C-16
one individualized compound I
Pyribencarb


C-17
one individualized compound I
Trifloxystrobin


C-18
one individualized compound I
Triclopyricarb/




Chlorodincarb


C-19
one individualized compound I
2-[2-(2,5-dimethyl-




phenoxymethyl)-phenyl]-3-




methoxy-acrylic acid methyl




ester


C-20
one individualized compound I
2-(2-(3-(2,6-dichlorophenyl)-




1-methyl-




allylideneaminooxymethyl)-




phenyl)-2-methoxyimino-




N-methyl-acetamide


C-21
one individualized compound I
Benalaxyl


C-22
one individualized compound I
Benalaxyl-M


C-23
one individualized compound I
Benodanil


C-24
one individualized compound I
Benzovindiflupyr


C-25
one individualized compound I
Bixafen


C-26
one individualized compound I
Boscalid


C-27
one individualized compound I
Carboxin


C-28
one individualized compound I
Fenfuram


C-29
one individualized compound I
Fenhexamid


C-30
one individualized compound I
Flutolanil


C-31
one individualized compound I
Fluxapyroxad


C-32
one individualized compound I
Furametpyr


C-33
one individualized compound I
Isopyrazam


C-34
one individualized compound I
Isotianil


C-35
one individualized compound I
Kiralaxyl


C-36
one individualized compound I
Mepronil


C-37
one individualized compound I
Metalaxyl


C-38
one individualized compound I
Metalaxyl-M


C-39
one individualized compound I
Ofurace


C-40
one individualized compound I
Oxadixyl


C-41
one individualized compound I
Oxycarboxin


C-42
one individualized compound I
Penflufen


C-43
one individualized compound I
Penthiopyrad


C-44
one individualized compound I
Sedaxane


C-45
one individualized compound I
Tecloftalam


C-46
one individualized compound I
Thifluzamide


C-47
one individualized compound I
Tiadinil


C-48
one individualized compound I
2-Amino-4-methyl-




thiazole-5-carboxylic




acid anilide


C-49
one individualized compound I
N-(4′-




trifluoromethylthiobiphenyl-




2-yl)-3-difluoromethyl-1-




methyl-1H-pyrazole-4-




carboxamide


C-50
one individualized compound I
N-(2-(1,3,3-trimethyl-




butyl)-phenyl)-1,3-dimethyl-




5-fluoro-1H-pyrazole-4-




carboxamide


C-51
one individualized compound I
3-(difluoromethyl)-1-methyl-




N-(1,1,3-trimethylindan-4-




yl)pyrazole-4-carboxamide


C-52
one individualized compound I
3-(trifluoromethyl)-1-methyl-




N-(1,1,3-trimethylindan-4-




yl)pyrazole-4-carboxamide


C-53
one individualized compound I
1,3-dimethyl-N-(1,1,3-




trimethylindan-4-yl)




pyrazole-4-carboxamide


C-54
one individualized compound I
3-(trifluoromethyl)-1,5-




dimethyl-N-(1,1,3-




trimethylindan-4-yl)




pyrazole-4-carboxamide


C-55
one individualized compound I
3-(difluoromethyl)-1,5-




dimethyl-N-(1,1,3-




trimethylindan-4-yl)




pyrazole-4-carboxamide


C-56
one individualized compound I
1,3,5-trimethyl-N-(1,1,3-




trimethylindan-4-yl)




pyrazole-4-carboxamide


C-57
one individualized compound I
Dimethomorph


C-58
one individualized compound I
Flumorph


C-59
one individualized compound I
Pyrimorph


C-60
one individualized compound I
Flumetover


C-61
one individualized compound I
Fluopicolide


C-62
one individualized compound I
Fluopyram


C-63
one individualized compound I
Zoxamide


C-64
one individualized compound I
Carpropamid


C-65
one individualized compound I
Diclocymet


C-66
one individualized compound I
Mandipropamid


C-67
one individualized compound I
Oxytetracyclin


C-68
one individualized compound I
Silthiofam


C-69
one individualized compound I
N-(6-methoxy-pyridin-3-yl)




cyclopropanecarboxylic




acid amide


C-70
one individualized compound I
Azaconazole


C-71
one individualized compound I
Bitertanol


C-72
one individualized compound I
Bromuconazole


C-73
one individualized compound I
Cyproconazole


C-74
one individualized compound I
Difenoconazole


C-75
one individualized compound I
Diniconazole


C-76
one individualized compound I
Diniconazole-M


C-77
one individualized compound I
Epoxiconazole


C-78
one individualized compound I
Fenbuconazole


C-79
one individualized compound I
Fluquinconazole


C-80
one individualized compound I
Flusilazole


C-81
one individualized compound I
Flutriafol


C-82
one individualized compound I
Hexaconazol


C-83
one individualized compound I
Imibenconazole


C-84
one individualized compound I
Ipconazole


C-85
one individualized compound I
Metconazole


C-86
one individualized compound I
Myclobutanil


C-87
one individualized compound I
Oxpoconazol


C-88
one individualized compound I
Paclobutrazol


C-89
one individualized compound I
Penconazole


C-90
one individualized compound I
Propiconazole


C-91
one individualized compound I
Prothioconazole


C-92
one individualized compound I
Simeconazole


C-93
one individualized compound I
Tebuconazole


C-94
one individualized compound I
Tetraconazole


C-95
one individualized compound I
Triadimefon


C-96
one individualized compound I
Triadimenol


C-97
one individualized compound I
Triticonazole


C-98
one individualized compound I
Uniconazole


C-99
one individualized compound I
1-[rel-(2S;3R)-3-(2-




chlorophenyl)-2-(2,4-




difluorophenyl)-




oxiranylmethyl]-5-




thiocyanato-1H-[1,2,




4]triazole,


C-100
one individualized compound I
2-[rel-(2S;3R)-3-(2-




chlorophenyl)-2-(2,




4-difluorophenyl)-




oxiranylmethyl]-2H-




[1,2,4]triazole-3-thiol


C-101
one individualized compound I
Cyazofamid


C-102
one individualized compound I
Amisulbrom


C-103
one individualized compound I
Imazalil


C-104
one individualized compound I
Imazalil-sulfate


C-105
one individualized compound I
Pefurazoate


C-106
one individualized compound I
Prochloraz


C-107
one individualized compound I
Triflumizole


C-108
one individualized compound I
Benomyl


C-109
one individualized compound I
Carbendazim


C-110
one individualized compound I
Fuberidazole


C-111
one individualized compound I
Thiabendazole


C-112
one individualized compound I
Ethaboxam


C-113
one individualized compound I
Etridiazole


C-114
one individualized compound I
Hymexazole


C-115
one individualized compound I
2-(4-Chloro-phenyl)-




N-[4-(3,4-dimeth-




oxy-phenyl)-isoxazol-




5-yl]-2-prop-2-yn-




yloxy-acetamide


C-116
one individualized compound I
Fluazinam


C-117
one individualized compound I
Pyrifenox


C-118
one individualized compound I
3-[5-(4-Chloro-phenyl)-




2,3-dimethyl-




isoxazolidin-3-yl]-




pyridine (Pyrisoxazole)


C-119
one individualized compound I
3-[5-(4-Methyl-phenyl)-




2,3-dimethyl-isoxazolidin-




3-yl]-pyridine


C-120
one individualized compound I
Bupirimate


C-121
one individualized compound I
Cyprodinil


C-122
one individualized compound I
5-Fluorocytosine


C-123
one individualized compound I
5-Fluoro-2-(p-




tolylmethoxy)pyrimidin-




4-amine


C-124
one individualized compound I
5-Fluoro-2-(4-




fluorophenylmethoxy)-




pyrimidin-4-amine


C-125
one individualized compound I
Diflumetorim


C-126
one individualized compound I
(5,8-Difluoroquinazolin-




4-yl)-{2-[2-fluoro-4-(4-




trifluoromethylpyridin-2-




yloxy)-phenyl]-ethyl}-amine


C-127
one individualized compound I
Fenarimol


C-128
one individualized compound I
Ferimzone


C-129
one individualized compound I
Mepanipyrim


C-130
one individualized compound I
Nitrapyrin


C-131
one individualized compound I
Nuarimol


C-132
one individualized compound I
Pyrimethanil


C-133
one individualized compound I
Triforine


C-134
one individualized compound I
Fenpiclonil


C-135
one individualized compound I
Fludioxonil


C-136
one individualized compound I
Aldimorph


C-137
one individualized compound I
Dodemorph


C-138
one individualized compound I
Dodemorph-acetate


C-139
one individualized compound I
Fenpropimorph


C-140
one individualized compound I
Tridemorph


C-141
one individualized compound I
Fenpropidin


C-142
one individualized compound I
Fluoroimid


C-143
one individualized compound I
Iprodione


C-144
one individualized compound I
Procymidone


C-145
one individualized compound I
Vinclozolin


C-146
one individualized compound I
Famoxadone


C-147
one individualized compound I
Fenamidone


C-148
one individualized compound I
Flutianil


C-149
one individualized compound I
Octhilinone


C-150
one individualized compound I
Probenazole


C-151
one individualized compound I
Fenpyrazamine


C-152
one individualized compound I
Acibenzolar-S-methyl


C-153
one individualized compound I
Ametoctradin


C-154
one individualized compound I
Amisulbrom


C-155
one individualized compound I
[(3S,6S,7R,8R)-8-benzyl-




3-[(3-isobutyryloxymethoxy-




4-methoxypyridine-




2-carbonyl)amino]-6-methyl-




4,9-dioxo-[1,5]dioxonan-7-yl]




2-methylpropanoate


C-156
one individualized compound I
[(3S,6S,7R,8R)-8-benzyl-




3-[(3-acetoxy-4-methoxy-




pyridine-2-carbonyl)amino]-




6-methyl-4,9-dioxo-1,5-




dioxonan-7-yl]2-




methylpropanoate


C-157
one individualized compound I
[(3S,6S,7R,8R)-8-benzyl-




3-[[3-(acetoxymethoxy)-




4-methoxy-pyridine-




2-carbonyl]amino]-6-




methyl-4,9-dioxo-1,5-




dioxonan-7-yl]2-




methylpropanoate


C-158
one individualized compound I
[(3S,6S,7R,8R)-8-




benzyl-3-[(3-isobut-




oxycarbonyloxy-4-




methoxy-pyridine-




2-carbonyl)amino]-6-




methyl-4,9-dioxo-




1,5-dioxonan-7-yl]2-




methylpropanoate


C-159
one individualized compound I
(3S,6S,7R,8R)-8-benzyl-




3-[[3-(1,3-benzodioxol-




5-ylmethoxy)-4-methoxy-




pyridine-2-carbonyl]amino]-




6-methyl-4,9-dioxo-




1,5-dioxonan-7-yl]2-methyl-




propanoate


C-160
one individualized compound I
(3S,6S,7R,8R)-3-[[(3-




hydroxy-4-methoxy-2-




pyridinyl)carbonyl]amino]-




6-methyl-4,9-dioxo-8-




(phenylmethyl)-1,5-




dioxonan-7-yl 2-




methylpropanoate


C-161
one individualized compound I
Anilazin


C-162
one individualized compound I
Blasticidin-S


C-163
one individualized compound I
Captafol


C-164
one individualized compound I
Captan


C-165
one individualized compound I
Chinomethionat


C-166
one individualized compound I
Dazomet


C-167
one individualized compound I
Debacarb


C-168
one individualized compound I
Diclomezine


C-169
one individualized compound I
Difenzoquat,


C-170
one individualized compound I
Difenzoquat-methylsulfate


C-171
one individualized compound I
Fenoxanil


C-172
one individualized compound I
Folpet


C-173
one individualized compound I
Oxolinsaure


C-174
one individualized compound I
Piperalin


C-175
one individualized compound I
Proquinazid


C-176
one individualized compound I
Pyroquilon


C-177
one individualized compound I
Quinoxyfen


C-178
one individualized compound I
Triazoxid


C-179
one individualized compound I
Tricyclazole


C-180
one individualized compound I
2-Butoxy-6-iodo-3-




propyl-chromen-4-one


C-181
one individualized compound I
5-Chloro-1-(4,6-




dimethoxy-pyrimidin-




2-yl)-2-methyl-1H-




benzoimidazole


C-182
one individualized compound I
5-Chloro-7-(4-methyl-




piperidin-1-yl)-6-(2,4,6-




trifluoro-phenyl)-[1,2,4]




triazolo[1,5-a]pyrimidine


C-183
one individualized compound I
Ferbam


C-184
one individualized compound I
Mancozeb


C-185
one individualized compound I
Maneb


C-186
one individualized compound I
Metam


C-187
one individualized compound I
Methasulphocarb


C-188
one individualized compound I
Metiram


C-189
one individualized compound I
Propineb


C-190
one individualized compound I
Thiram


C-191
one individualized compound I
Zineb


C-192
one individualized compound I
Ziram


C-193
one individualized compound I
Diethofencarb


C-194
one individualized compound I
Benthiavalicarb


C-195
one individualized compound I
Iprovalicarb


C-196
one individualized compound I
Propamocarb


C-197
one individualized compound I
Propamocarb hydrochlorid


C-198
one individualized compound I
Valifenalate


C-199
one individualized compound I
N-(1-(1-(4-cyanophenyl)




ethanesulfon-yl)-but-2-




yl) carbamic acid-(4-fluoro-




phenyl) ester


C-200
one individualized compound I
Dodine


C-201
one individualized compound I
Dodine free base


C-202
one individualized compound I
Guazatine


C-203
one individualized compound I
Guazatine-acetate


C-204
one individualized compound I
Iminoctadine


C-205
one individualized compound I
Iminoctadine-triacetate


C-206
one individualized compound I
Iminoctadine-tris(albesilate)


C-207
one individualized compound I
Kasugamycin


C-208
one individualized compound I
Kasugamycin-




hydrochloride-hydrate


C-209
one individualized compound I
Polyoxine


C-210
one individualized compound I
Streptomycin


C-211
one individualized compound I
Validamycin A


C-212
one individualized compound I
Binapacryl


C-213
one individualized compound I
Dicloran


C-214
one individualized compound I
Dinobuton


C-215
one individualized compound I
Dinocap


C-216
one individualized compound I
Nitrothal-isopropyl


C-217
one individualized compound I
Tecnazen


C-218
one individualized compound I
Fentin salts


C-219
one individualized compound I
Dithianon


C-220
one individualized compound I
2,6-dimethyl-1H,5H-[1,4]




dithiino[2,3-c:5,6-c′]




dipyrrole-1,3,5,7(2H,6H)-




tetraone


C-221
one individualized compound I
Isoprothiolane


C-222
one individualized compound I
Edifenphos


C-223
one individualized compound I
Fosetyl, Fosetyl-aluminium


C-224
one individualized compound I
Iprobenfos


C-225
one individualized compound I
Phosphorous acid (H3PO3)




and derivatives


C-226
one individualized compound I
Pyrazophos


C-227
one individualized compound I
Tolclofos-methyl


C-228
one individualized compound I
Chlorothalonil


C-229
one individualized compound I
Dichlofluanid


C-230
one individualized compound I
Dichlorophen


C-231
one individualized compound I
Flusulfamide


C-232
one individualized compound I
Hexachlorbenzene


C-233
one individualized compound I
Pencycuron


C-234
one individualized compound I
Pentachlorophenol and salts


C-235
one individualized compound I
Phthalide


C-236
one individualized compound I
Quintozene


C-237
one individualized compound I
Thiophanate Methyl


C-238
one individualized compound I
Tolylfluanid


C-239
one individualized compound I
N-(4-chloro-2-nitro-




phenyl)-N-ethyl-4-




methyl-benzenesulfonamide


C-240
one individualized compound I
Bordeaux composition


C-241
one individualized compound I
Copper acetate


C-242
one individualized compound I
Copper hydroxide


C-243
one individualized compound I
Copper oxychloride


C-244
one individualized compound I
basic Copper sulfate


C-245
one individualized compound I
Sulfur


C-246
one individualized compound I
Biphenyl


C-247
one individualized compound I
Bronopol


C-248
one individualized compound I
Cyflufenamid


C-249
one individualized compound I
Cymoxanil


C-250
one individualized compound I
Diphenylamin


C-251
one individualized compound I
Metrafenone


C-252
one individualized compound I
Pyriofenone


C-253
one individualized compound I
Mildiomycin


C-254
one individualized compound I
Oxin-copper


C-255
one individualized compound I
Oxathiapiprolin


C-256
one individualized compound I
Prohexadione calcium


C-257
one individualized compound I
Spiroxamine


C-258
one individualized compound I
Tebufloquin


C-259
one individualized compound I
Tolylfluanid


C-260
one individualized compound I
N-(Cyclopropyl-




methoxyimino-(6-




difluoromethoxy-2,




3-difluoro-phenyl)-




methyl)-2-phenyl




acetamide


C-261
one individualized compound I
N′-(4-(4-chloro-3-




trifluoromethyl-




phenoxy)-2,5-dimethyl-




phenyl)-N-ethyl-




N-methyl formamidine


C-262
one individualized compound I
N′-(4-(4-fluoro-3-




trifluoromethyl-




phenoxy)-2,5-dimethyl-




phenyl)-N-ethyl-




N-methyl formamidine


C-263
one individualized compound I
N′-(2-methyl-5-




trifluoromethyl-4-(3-tri-




methylsilanyl-propoxy)-




phenyl)-N-ethyl-




N-methyl formamidine


C-264
one individualized compound I
N′-(5-difluoromethyl-2-




methyl-4-(3-tri-




methylsilanyl-propoxy)-




phenyl)-N-ethyl-




N-methyl formamidine


C-265
one individualized compound I
Methoxy-acetic acid 6-




tert-butyl-8-fluoro-2,3-




dimethyl-quinolin-4-yl ester


C-266
one individualized compound I

Bacillus subtilis NRRL




No. B-21661


C-267
one individualized compound I

Bacillus pumilus NRRL




No. B-30087


C-268
one individualized compound I

Ulocladium oudemansii



C-269
one individualized compound I
Carbaryl


C-270
one individualized compound I
Carbofuran


C-271
one individualized compound I
Carbosulfan


C-272
one individualized compound I
Methomylthiodicarb


C-273
one individualized compound I
Bifenthrin


C-274
one individualized compound I
Cyfluthrin


C-275
one individualized compound I
Cypermethrin


C-276
one individualized compound I
alpha-Cypermethrin


C-277
one individualized compound I
zeta-Cypermethrin


C-278
one individualized compound I
Deltamethrin


C-279
one individualized compound I
Esfenvalerate


C-280
one individualized compound I
Lambda-cyhalothrin


C-281
one individualized compound I
Permethrin


C-282
one individualized compound I
Tefluthrin


C-283
one individualized compound I
Diflubenzuron


C-284
one individualized compound I
Flufenoxuron


C-285
one individualized compound I
Lufenuron


C-286
one individualized compound I
Teflubenzuron


C-287
one individualized compound I
Spirotetramate


C-288
one individualized compound I
Clothianidin


C-289
one individualized compound I
Dinotefuran


C-290
one individualized compound I
Imidacloprid


C-291
one individualized compound I
Thiamethoxam


C-292
one individualized compound I
Flupyradifurone


C-293
one individualized compound I
Acetamiprid


C-294
one individualized compound I
Thiacloprid


C-295
one individualized compound I
Endosulfan


C-296
one individualized compound I
Fipronil


C-297
one individualized compound I
Abamectin


C-298
one individualized compound I
Emamectin


C-299
one individualized compound I
Spinosad


C-300
one individualized compound I
Spinetoram


C-301
one individualized compound I
Hydramethylnon


C-302
one individualized compound I
Chlorfenapyr


C-303
one individualized compound I
Fenbutatin oxide


C-304
one individualized compound I
Indoxacarb


C-305
one individualized compound I
Metaflumizone


C-306
one individualized compound I
Flonicamid


C-307
one individualized compound I
Lubendiamide


C-308
one individualized compound I
Chlorantraniliprole


C-309
one individualized compound I
Cyazypyr (HGW86)


C-310
one individualized compound I
Cyflumetofen


C-311
one individualized compound I
Acetochlor


C-312
one individualized compound I
Dimethenamid


C-313
one individualized compound I
metolachlor


C-314
one individualized compound I
Metazachlor


C-315
one individualized compound I
Glyphosate


C-316
one individualized compound I
Glufosinate


C-317
one individualized compound I
Sulfosate


C-318
one individualized compound I
Clodinafop


C-319
one individualized compound I
Fenoxaprop


C-320
one individualized compound I
Fluazifop


C-321
one individualized compound I
Haloxyfop


C-322
one individualized compound I
Paraquat


C-323
one individualized compound I
Phenmedipham


C-324
one individualized compound I
Clethodim


C-325
one individualized compound I
Cycloxydim


C-326
one individualized compound I
Profoxydim


C-327
one individualized compound I
Sethoxydim


C-328
one individualized compound I
Tepraloxydim


C-329
one individualized compound I
Pendimethalin


C-330
one individualized compound I
Prodiamine


C-331
one individualized compound I
Trifluralin


C-332
one individualized compound I
Acifluorfen


C-333
one individualized compound I
Bromoxynil


C-334
one individualized compound I
Imazamethabenz


C-335
one individualized compound I
Imazamox


C-336
one individualized compound I
Imazapic


C-337
one individualized compound I
Imazapyr


C-338
one individualized compound I
Imazaquin


C-339
one individualized compound I
Imazethapyr


C-340
one individualized compound I
2,4-Dichloro-




phenoxyacetic acid (2,4-D)


C-341
one individualized compound I
Chloridazon


C-342
one individualized compound I
Clopyralid


C-343
one individualized compound I
Fluroxypyr


C-344
one individualized compound I
Picloram


C-345
one individualized compound I
Picolinafen


C-346
one individualized compound I
Bensulfuron


C-347
one individualized compound I
Chlorimuron-ethyl


C-348
one individualized compound I
Cyclosulfamuron


C-349
one individualized compound I
Iodosulfuron


C-350
one individualized compound I
Mesosulfuron


C-351
one individualized compound I
Metsulfuron-methyl


C-352
one individualized compound I
Nicosulfuron


C-353
one individualized compound I
Rimsulfuron


C-354
one individualized compound I
Triflusulfuron


C-355
one individualized compound I
Atrazine


C-356
one individualized compound I
Hexazinone


C-357
one individualized compound I
Diuron


C-358
one individualized compound I
Florasulam


C-359
one individualized compound I
Pyroxasulfone


C-360
one individualized compound I
Bentazone


C-361
one individualized compound I
Cinidon-ethyl


C-362
one individualized compound I
Cinmethylin


C-363
one individualized compound I
Dicamba


C-364
one individualized compound I
Diflufenzopyr


C-365
one individualized compound I
Quinclorac


C-366
one individualized compound I
Quinmerac


C-367
one individualized compound I
Mesotrione


C-368
one individualized compound I
Saflufenacil


C-369
one individualized compound I
Topramezone









The active substances referred to as component 2, their preparation and their activity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; U.S. Pat. No. 3,296,272; U.S. Pat. No. 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 11/028657).


The compositions of active substances can be prepared as compositions comprising besides the active ingredients at least one inert ingredient by usual means, e. g. by the means given for the compositions of compounds I.


Concerning usual ingredients of such compositions reference is made to the explanations given for the compositions containing compounds I.


The compositions of active substances according to the present invention are suitable as fungicides, as are the compounds of formula I. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, especially from the classes of the Ascomycetes, Basidiomycetes, Deuteromycetes and Peronosporomycetes (syn. Oomycetes). In addition, it is referred to the explanations regarding the fungicidal activity of the compounds and the compositions containing compounds I, respectively.







SYNTHESIS EXAMPLES

With due modification of the starting compounds, the procedures shown in the synthesis examples below were used to obtain further compounds I. The resulting compounds, together with physical data, are listed in Table I below.


I. Synthesis Example
1) Synthese 6-Methyl-5H-Pyrrolo[3″,4″:5,6][1,4]dithiino-[2,3-C]isothiazole-3-carbonitrile-5,7(6H)-dione

To the mixture of 0.69 g 3,4-dichloro-1-methyl-pyrrole-2,5-dione in 20 ml DMF added 1 g disodium 5-cyanoisothiazoledithiolate and the mixture stirred 3 h at 50° C. To the reaction mixture added 60 ml MtBE and washed with water. The organic phase was evaporated to dryness under reduced pressure and the crude product was purified by column chromatography using cyclohexan/MtBE (9:1) as eluent to yield 0.89 g of the titled product.



1H-NMR (CDCl3): δ=3.1 (s, 3H) ppm


MP: 203-211° C.


According to the synthesis example compounds of the formula I were prepared as listed in the Table 1:









TABLE 1







Compounds of formula I with physical data (melting point [° C.]; 1H-NMR [CDCl3,


δ].












No.
R1
R2
k
l
m.p [° C.]; 1H-NMR [CDCl3, δ].





1.1
CH3
CN
0
0
206° C.


1.2
CH2CH3
CN
0
0
206° C.


1.3
CH2CH2CH═CH2
CN
0
0
189° C.


1.4
CH(CH3)2
CN
0
0
170° C.


1.5
CH2CH2CH3
CN
0
0
175° C.


1.6
CH2CH═CH2
CN
0
0
184° C.


1.7
cyclopentan
CN
0
0
178° C.


1.8
CH2CF3
CN
0
0
242° C.


1.9
cyclopropan
CN
0
0
243° C.


1.10
CH(CH3)CH(OCH3)2
CN
0
0
119° C.


1.11
OCH2CH3
CN
0
0
158° C.


1.12
OCH3
CN
0
0
210° C.


1.13
CH2CH3
C(═O)NH2
0
0
1H-NMR: 8.5 (s); 8.2 (s); 3.5 (q); 1.0 (t)


1.14
H
CN
0
0
290° C.


1.15
CH2CH3
C(═O)OCH3
0
0
1H-NMR: 1.1 (s); 3.45 (q); 3.9







(s)









II. Examples of the Action Against Harmful Fungi

The fungicidal action of the compounds of the formula I was demonstrated by the following experiments:


A) Green House


The spray solutions were prepared in several steps:


The stock solution were prepared: a mixture of acetone and/or dimethylsulfoxide and the wetting agent/emulsifier Wettol, which is based on ethoxylated alkylphenoles, in a relation (volume) solvent-emulsifier of 99 to 1 was added to 25 mg of the compound to give a total of 5 ml.


Water was then added to total volume of 100 ml.


This stock solution was diluted with the described solvent-emulsifier-water mixture to the given concentration.


Example 1
Protective Control of Soy Bean Rust on Soy Beans Caused by Phakopsora pachyrhizi

Leaves of pot-grown soy bean seedlings were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The plants were allowed to air-dry. The trial plants were cultivated for 1 day in a greenhouse chamber at 23-27° C. and a relative humidity between 60 and 80%. Then the plants were inoculated with spores of Phakopsora pachyrhizi. To ensure the success the artificial inoculation, the plants were transferred to a humid chamber with a relative humidity of about 95% and 20 to 24° C. for 24 h. The trial plants were cultivated for fourteen days in a greenhouse chamber at 23-27° C. and a relative humidity between 60 and 80%. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1 and 1.2 showed an infection of less than or equal to 7% whereas the untreated plants were 90% infected.


Example 2
Control of Late Blight on Tomatoes Caused by Phytophthora infestans

Young seedlings of tomato plants were grown in pots. These plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture mentioned in the table below. The next day, the treated plants were inoculated with an aqueous suspension of sporangia of Phytophthora infestans. After inoculation, the trial plants were immediately transferred to a humid chamber. After 6 days at 18 to 20° C. and a relative humidity close to 100% the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1 and 1.2 showed an infection of less than or equal to 0% whereas the untreated plants were 90% infected.


Example 3
Preventative Fungicidal Control of Early Blight on Tomatoes (Alternaria solani)

Young seedlings of tomato plants were grown in pots. These plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or mixture mentioned in the table below. The next day, the treated plants were inoculated with an aqueous suspension of Alternaria solani. Then the trial plants were immediately transferred to a humid chamber. After 5 days at 18 to 20° C. and a relative humidity close to 100%, the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1 and 1.2 showed an infection of less than or equal to 5% and 1% respectively whereas the untreated plants were 90% infected.


Example 4
Preventative Control of Leaf Blotch on Wheat Caused by Septoria tritici

Leaves of pot-grown wheat seedling were sprayed to run-off with an aqueous suspension of the active compound or their mixture, prepared as described. The plants were allowed to air-dry. At the following day the plants were inoculated with an aqueous spore suspension of Septoria tritici. Then the trial plants were immediately transferred to a humid chamber at 18-22° C. and a relative humidity close to 100%. After 4 days the plants were transferred to a chamber with 18-22° C. and a relative humidity close to 70%. After 4 weeks the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1 and 1.2 showed an infection of less than or equal to 3% and 10% respectively whereas the untreated plants were 90% infected.


Example 5
Protective Control of Soy Bean Rust on Soy Beans Caused by Phakopsora pachyrhizi

Leaves of pot-grown soy bean seedlings were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The plants were allowed to air-dry. The trial plants were cultivated for 1 day in a greenhouse chamber at 23-27° C. and a relative humidity between 60 and 80%. Then the plants were inoculated with spores of Phakopsora pachyrhizi. To ensure the success the artificial inoculation, the plants were transferred to a humid chamber with a relative humidity of about 95% and 20 to 24° C. for 24 h. The trial plants were cultivated for fourteen days in a greenhouse chamber at 23-27° C. and a relative humidity between 60 and 80%. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1, 1.2, 1.4 and 1.6 showed an infection of less than or equal to 1%, 3% and 10% respectively whereas the untreated plants were 90% infected.


Example 6
Preventative Control of Leaf Blotch on Wheat Caused by Septoria tritici

Leaves of pot-grown wheat seedling were sprayed to run-off with an aqueous suspension of the active compound or their mixture, prepared as described. The plants were allowed to air-dry. At the following day the plants were inoculated with an aqueous spore suspension of Septoria tritici. Then the trial plants were immediately transferred to a humid chamber at 18-22° C. and a relative humidity close to 100%. After 4 days the plants were transferred to a chamber with 18-22° C. and a relative humidity close to 70%. After 4 weeks the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.


In this test, the plants which had been treated with 500 ppm of the active substance from examples 1.1, 1.2, 1.4, 1.5, 1.6, 1.11 and 1.12 showed an infection of less between 7% to 15% whereas the untreated plants were 90% infected.

Claims
  • 1-14. (canceled)
  • 15. A compound of the formula I
  • 16. The compound according to claim 15, wherein R2 is CN.
  • 17. The compound according to claim 15, wherein R2 is NO2.
  • 18. The compound according to claim 15, wherein R2 is —C(═O)A4.
  • 19. The compound according to claim 15, wherein R2 is —C(═O)OA4.
  • 20. The compound according to claim 15, wherein R1 is C1-C10-alkyl.
  • 21. The compound according to claim 15, wherein R1 is C1-C10-alkoxy.
  • 22. The compound according to claim 15, wherein R1 is NA1A2.
  • 23. A process for preparing compounds of formula I as defined in claim 15, which comprises reacting a compound of formula III
  • 24. Agrochemical compositions, wherein said composition comprise an auxiliary and at least one compound of formula I, as defined in claim 15, an N-oxide or an agriculturally acceptable salt thereof.
  • 25. The compositions according to claim 10, comprising additionally a further active substance.
  • 26. A method for combating harmful fungi, comprising treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of at least one compound of formula I, as defined in claim 15.
  • 27. The method according to claim 26, wherein, in the compound of formula I, R2 is CN.
  • 28. The method according to claim 26, wherein, in the compound of formula I, R2 is NO2.
  • 29. The method according to claim 26, wherein, in the compound of formula I, R2 is —C(═O)A4.
  • 30. The method according to claim 26, wherein, in the compound of formula I, R2 is —C(═O)OA4.
  • 31. The method according to claim 26, wherein, in the compound of formula I, R1 is C1-C10-alkyl.
  • 32. The method according to claim 26, wherein, in the compound of formula I, R1 is C1-C10-alkoxy.
  • 33. The method according to claim 26, wherein, in the compound of formula I, R1 is NA1A2.
  • 34. Seed, coated with at least one compound of the formula I, as defined in claim 15, and/or an agriculturally acceptable salt thereof in an amount of from 0.1 to 10 kg per 100 kg of seed.
Priority Claims (1)
Number Date Country Kind
12195501.7 Dec 2012 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2013/074529 11/25/2013 WO 00